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Abstract 
Inherited diseases occur across different species. This thesis work has provided insights 
into the molecular genetic background of three autosomal recessive diseases that affect 
specific dog breeds. The studied phenotypes comprised two neurodegenerative diseases 
and a type of skeletal dysplasia. Genome-wide methods, such as SNP chip genotyping, 
were used to identify disease-associated gene variants. In all three disease phenotypes, 
the likely causative variant was found in a gene that had not been previously associated 
with a monogenic disorder.  
The Norwegian Elkhound and Karelian Bear Dog breeds are affected with inherited 
chondrodysplasia that causes short-stature dwarfism of varying severity. A genome-
wide association study in Norwegian Elkhounds revealed a disease-associated locus on 
canine chromosome 17 and a nonsense mutation in the ITGA10 gene. The identified 
mutation was homozygous in all affected dogs from both breeds, and may have been 
introduced to Karelian Bear Dogs from Norwegian Elkhounds. The ITGA10 gene 
encodes an α10-integrin protein that assembles into a collagen-binding α10β1 integrin. 
The α10β1 integrin is a cell surface receptor, found in growth plate chondrocytes, where 
it mediates the cell’s attachments with the surrounding matrix. Due to the mutation, a 
full-length α10-protein is not produced, disturbing the growth of long bones. 
Early-onset cerebellar degeneration occurs in the Finnish Hound dog breed. 
Neurological examination of affected dogs revealed quickly progressing cerebellar 
ataxia and failure to thrive. Genome-wide association analyses mapped the disease to a 
1.5-Mb locus on canine chromosome 8. Sequencing of the SEL1L gene from the locus 
identified a homozygous missense mutation in all affected dogs. The mutation causes a 
serine to proline amino acid change within a highly conserved functional domain of the 
encoded SEL1L protein. The SEL1L protein is found in the endoplasmic reticulum, 
where it functions within a protein quality control and degradation pathway. Cerebellar 
tissue samples from affected dogs showed signs of endoplasmic reticulum stress, which 
may be the cause of premature cell death. 
A novel neurological disease, characterized by juvenile to adult onset cerebellar 
ataxia, was recognized in the Lagotto Romagnolo breed. Through linkage analysis, 
homozygosity mapping and whole-genome sequencing, the disease was associated with 
a homozygous missense change in the autophagy-related ATG4D gene. Pathological 
examination of affected dogs revealed progressive cerebellar degeneration, and 
intracellular vacuolar changes both in neuronal and extraneuronal tissues. The ATG4D 
gene encodes a cysteine protease, which is thought to function in the macroautophagy 
pathway. The autophagy process degrades and recycles damaged or obsolete cellular 
materials via membrane-enclosed autophagosomes. In line with this, the neuronal 
tissues of affected dogs showed signs of altered autophagic flow.  
Overall, this study has revealed three new disease-linked genes in dogs, which may 
be associated to similar disorders in other species. On the basis of the results, DNA-tests 
have been developed for veterinary diagnostic and breeding purposes. Importantly, by 
shedding light into disease-causing pathways, the results of this study could prove 
beneficial not just for canine health but for human medicine as well.  
 
 
 
 
Tiivistelmä 
Perinnöllisiä sairauksia tavataan ihmisten lisäksi myös muissa lajeissa, kuten 
kotieläimissä. Tässä väitöskirjatyössä tutkittiin kolmea koirissa esiintyvää peittyvästi 
periytyvää sairautta. Tutkimuksen kohteena oli lyhytkasvuisuutta aiheuttava 
luustosairaus sekä kaksi erityyppistä hermostorappeumasairautta. Tutkimuksessa 
käytettiin hyväksi koko perimän laajuisia tutkimusmenetelmiä, joiden avulla 
paikannettiin sairauksien taustalla olevat geenivirheet.  
Harmaissa norjanhirvikoirissa sekä karjalankarhukoirissa esiintyy kondrodysplasiaa, 
eli rustonsisäisen luutumisen häiriötä, joka ilmenee lyhytkasvuisuutena. Sairaiden 
koirien raajat ovat huomattavan lyhyet ja näillä esiintyy myös muita vakavuudeltaan 
vaihtelevia luustomuutoksia. Kummankin rodun lyhytkasvuisilta koirilta löytyi 
homotsygoottinen geenivirhe ITGA10-geenistä. Tutkimustulosten perusteella geenivirhe 
on saattanut siirtyä karjalankarhukoiriin harmaista norjanhirvikoirista. ITGA10-geeni 
koodaa α10-intergriini proteiinia, joka on osa kasvulevyjen rustosoluissa toimivaa, 
kollageeneja sitovaa α10β1-integriini reseptoria. Geenivirhe estää α10-proteiinin 
normaalin tuoton, minkä seurauksena kasvulevyn toiminta sekä luuston kasvu 
häiriintyy. 
Suomenajokoirilla tavataan pentuiän pikkuaivorappeumaa, jota aiheuttava 
geenivirhe löytyi SEL1L-geenistä. Sairaat ajokoiranpennut kärsivät nopeasti etenevästä 
pikkuaivoataksiasta, eli liikkeiden säätelyn vaikeudesta. Pennuilta tunnistettiin SEL1L-
geenistä homotsygoottinen yhden emäksen muutos, joka johtaa yhden aminohapon 
vaihtumiseen toiseksi SEL1L-proteiinin toiminnallisesti tärkeässä rakenteessa. SEL1L-
proteiini toimii solulimakalvostossa proteiinien laaduntarkkailussa. Tunnistetun 
geenivirheen oletetaan aiheuttavan häiriöitä solulimakalvossa, mikä puolestaan 
vaikuttaa pikkuaivojen hermosolujen solunsisäinen tasapainoon ja johtaa 
ennenaikaiseen solukatoon. 
Lagotto romagnolo -rodusta tunnistettiin uuden tyypin neurologinen sairaus, jonka 
pääasiallinen oire on etenevä, nuoruus- tai aikuisiällä alkava pikkuaivoataksia. 
Patologiset tutkimukset paljastivat solutason muutoksia paitsi keskushermostosta, mutta 
myös muualta elimistöstä. Pikkuaivoissa nähtiin etenevää hermosolukatoa. Sairauteen 
liitettiin homotsygoottinen yhden emäksen muutos ATG4D-geenissä. ATG4D-geenin 
toiminta liittyy autofagosytoosiin, joka on solunsisäinen puhdistus- ja ravinteiden 
kierrätys mekanismi. Sairaiden koirien keskushermostosta löytyikin viitteitä 
autofagosytoosin häiriintymisestä. 
Kyseisiä geenejä ei ole aiemmin liitetty vastaaviin sairauksiin muissa lajeissa, mikä 
on antanut uutta tietoa sairauksiin liittyvistä molekyylireiteistä. Tästä tiedosta saattaa 
tulevaisuudessa olla hyötyä myös ihmislääketieteessä. Tutkimustulokset ovat lisäksi 
mahdollistaneet geenivirheitä kantavien koirien tunnistamisen DNA-testeillä. 
Testauksen avulla voidaan estää sairaiden koirien syntyminen sekä saada tukea 
eläinlääketieteelliseen diagnostiikkaan. 
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1 Introduction 
The genome sequence of the domestic dog (Canis lupus familiaris) was published in 
2005 (Lindblad-Toh et al. 2005), only a few years after the completion of the initial 
sequence draft of the human genome in 2001 (Lander et al. 2001, Venter et al. 2001). 
At present, the number of sequenced genomes is expanding at a very rapid rate, owing 
to advancements in the next generation high-throughput sequencing technologies. This 
progress has provided researchers valuable tools to conduct genetic studies in various 
different species and model organisms. 
The domestic dog has proved to be a very useful model to delineate the molecular 
genetic background of different diseases and traits. Due to decades of artificial selection 
and inbreeding, inherited diseases have become common in the modern dog breeds. 
Recent discoveries have shed light into the genetic basis of several canine inherited 
diseases, but many remain to be studied further, and there likely are many more that 
have not yet been recognized. Apart from being beneficial to canine health, genetic 
studies in dogs can have broader significance, for instance by providing basic 
understanding of the pathways and mechanisms involved in disease pathogenesis. 
Furthermore, given that many canine disorders correspond with human conditions, both 
in regard to the clinical phenotype and the underlying molecular defect, the dog is a 
highly relevant model for human diseases. 
There are several practical advantages in studying inherited diseases in purebred 
dogs. These include the availability of samples from several generations, as well as the 
availability of extensive pedigree records that can be utilized in determining inheritance 
patterns. Moreover, the population history of modern breeds had an impact on the dog 
genome, namely in the form of extensive linkage disequilibrium (LD) within breeds, 
which enables genome-wide studies to be performed using low sample and marker 
numbers (Karlsson et al. 2007).  
During the course of this thesis work, breed clubs and dog owners have participated 
in the canine genetic research in large numbers. Starting from 2006, DNA-samples from 
over 50,000 pet dogs have been donated to the dog DNA bank maintained at the 
University of Helsinki. Alongside the physical DNA repository, a digital database holds 
comprehensive health information from the sampled animals. By utilizing these 
resources, this study has provided insights into the genetics of three canine recessive 
disorders, a short-stature dwarfism, and two types of progressive neurodegenerative 
disease.   
Review of the literature 
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2 Review of the literature 
2.1 The domestic dog in genetic research 
2.1.1 Dog domestication and the origin of breed structure 
The dog is believed to have been domesticated from the gray wolf (Canis lupus) before 
the rise of agriculture (Vila et al. 1997, Lindblad-Toh et al. 2005). Recent genetic 
studies estimate that the domestication event took place somewhere between 11,000 to 
30,000 years ago (ya) (Pang et al. 2009, Thalmann et al. 2013, Freedman et al. 2014). 
However, the question of exactly when, where and how has remained controversial 
(Savolainen et al. 2002, Pang et al. 2009, Boyko et al. 2009, Vonholdt et al. 2010, Ding 
et al. 2012, Thalmann et al. 2013, Freedman et al. 2014). For instance, mitochondrial 
and Y-chromosomal data from modern dogs support a single origin in Southeast Asia 
less than 16,300 ya (Pang et al. 2009, Ding et al. 2012), whereas mitochondrial 
genomes of ancient canids suggest an older origin in Europe between 18,800 to 32,100 
ya (Thalmann et al. 2013). Likewise, analysis of whole genome sequence data from 
present-day dogs and wolves implicates a time of divergence between 11,000 and 
16,000 ya (Freedman et al. 2014), whereas the genome sequence of an ancient wolf 
suggests that the ancestors of modern dogs and wolves diverged at least 27,000 ya 
(Skoglund et al. 2015). Some of the earliest dog-like fossils, dating more than 30,000 
years, have been found in Siberia (Ovodov et al. 2011, Druzhkova et al. 2013) and 
Belgium (Germonpré et al. 2009, Thalmann et al. 2013), but whether these remains 
belong to early domesticated dogs or other canids is unsure (Ovodov et al. 2011, Drake 
et al. 2015). It is also possible that several domestication attempts may have taken place 
at different locations in different times and some of the resulting lineages have gone 
extinct (Thalmann et al. 2013). In addition, there is evidence of later admixture with 
wolf populations, which might also complicate the scenario (Vonholdt et al. 2010, 
Skoglund et al. 2015). However, regardless of the exact time and location of 
domestication, the dog has since spread to all corners of the world, serving various roles 
among human populations. 
The current global dog population consists not only of purebred dogs, but also of 
different kinds of local dog types, mixed-breed dogs and free-ranging dogs that live in 
rural and urban environments. Semi-feral indigenous “village dogs” are for instance 
found in different parts of Africa and Asia (Boyko et al. 2009). At the moment, over 
400 dog breeds are recognized worldwide, most of which are of European origin and 
have been created during the last few hundreds of years (Parker et al. 2004, Larson et 
al. 2012). After domestication, human selection is thought to have acted largely on 
behavior, such as herding, hunting or guarding, whereas more recently, the emphasis 
has shifted to appearance. The current breeds are the result of intense artificial selection, 
which has acted on different behavioral and morphological characteristics and resulted 
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in a tremendous amount of phenotypic variation within a single species (Galibert & 
André 2008). However, the phenotype of animals within each breed is typically very 
homogeneous. Detailed breed standards have been employed to define the desired 
behavior and appearance, which has led to the fixation of these traits within breeds. The 
“breed barrier” rule states that for a dog to be registered to a particular breed, both of its 
parents need to be registered to the same breed (Schoenebeck & Ostrander 2014). In 
practice, this has made each breed a genetic isolate, preventing gene flow across breed 
borders. Furthermore, the mating of close relatives with each other and the use of 
“popular sires” with hundreds of offspring has been common practice in the recent past 
(Calboli et al. 2008).  
Present-day breeds have been formed through several bottlenecks; the major ones 
being the domestication and breed formation processes (Fig. 1A) (Lindblad-Toh et al. 
2005, Freedman et al. 2014). Catastrophic events, such as the World Wars, have also 
had a large impact on the population sizes of several breeds (Galibert & André 2008, 
Larson et al. 2012). As a consequence of the bottlenecks and strict breeding practices, 
the phenotypic variation and genetic diversity is higher across breeds than within 
breeds. Dogs from a given breed are genetically more similar to each other than to dogs 
from other breeds, and breeds that are morphologically similar or originate from the 
same geographical region tend to cluster together on the basis of genetic data (Parker et 
al. 2004, Vonholdt et al. 2010). The population history of breeds has also given rise to a 
particular genomic structure, which is characterized by long-range LD within breeds 
and short-range LD across breeds, the latter of which reflects the genomic structure and 
short haplotype blocks of the pre-breed dog populations (Fig. 1B) (Lindblad-Toh et al. 
2005). Within the breeds, LD can extend to megabases, when the size of the short 
ancestral haplotype blocks is only 5-15 kb (Sutter et al. 2004, Lindblad-Toh et al. 
2005). In comparison, the LD of human populations is typically measured in a few tens 
of kilobases (Reich et al. 2001, Wall & Pritchard 2003). 
2.1.2 Dogs can be used to understand inherited diseases 
Dogs are reported to suffer from the second largest number of naturally occurring 
inherited diseases after humans (Patterson 2000, Sargan 2004). Mutations that cause 
monogenic diseases, and risk alleles that predispose to complex disorders, have been 
enriched within breeds as a consequence of the population bottlenecks and breeding 
practices. Diseases are often breed-specific or found only in a few related breeds. 
Autosomal recessive disorders are particularly frequent, as it has been easier for 
breeders to eradicate dominant than recessive conditions. Furthermore, the use of 
popular sires has very effectively spread recessive disease alleles in many breeds, a 
problem that has become apparent after a few generations (Patterson 2000, Ostrander & 
Kruglyak 2000). In some cases, artificial selection has favored monogenic phenotypes, 
which in dogs are referred to as traits, but in humans are considered pathological 
conditions, such as chondrodysplasia (causing short-stature) (Parker et al. 2009) or 
ectodermal dysplasia (causing hairlessness) (Drogemuller et al. 2008). The OMIA 
Review of the literature 
 
 
 
 
14 
database (Online Mendelian Inheritance in Animals) currently lists ~650 diseases and 
traits in dogs, over 260 of which are simple Mendelian phenotypes. Furthermore, nearly 
200 of the phenotypes have been molecularly delineated, including traits such as coat 
color and type, and diseases such as developmental disorders, eye diseases, skeletal 
disorders, neurodegenerative phenotypes and metabolic diseases (http://omia.angis. 
org.au/).  
 
 
 
Figure 1. Domestication and haplotype structure of modern dog breeds. Both old and 
recent bottlenecks have shaped the haplotype structure and LD in current dog 
breeds. A) Bottlenecks have been introduced by ancient domestication events, as 
well as the creation of modern breeds in the recent past. B) Before modern breeds 
were created, the dog population had a short-range LD structure. When subsets of 
dogs from this population were used to form the current breeds, the short ancestral 
haplotypes, which happened to be carried out on to the new breeds, formed the 
long-range LD pattern and haplotypes seen today. Because breed creation is a 
recent event, recombination has not yet had a large impact on the haplotype 
structure. The figure is adapted from Lindblad-Toh et al. 2005 and Karlsson & 
Lindblad-Toh 2008. Image sources: Wolf and dog drawings (Wikimedia Commons, 
Archives of Pearson Scott Foresman). 
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The dog is not a replacement for traditional model organisms, such as the mouse, but it 
can be used as a platform to understand the molecular basis of hereditary diseases in 
humans and other species. Dogs are close to humans in size and physiology and they 
also share our environment, and in these respects, can be considered a good model for 
human diseases (Ostrander & Kruglyak 2000). In many cases, inherited diseases in dogs 
have proved to be caused by mutations in genes that have already been linked to similar 
disease phenotypes in humans (Katz et al. 2005, Goldstein et al. 2010, Ahonen et al. 
2013). However, new disease-linked genes and pathways have also emerged (Patterson 
et al. 2008, Seppälä et al. 2011, Olsson et al. 2011, Grall et al. 2012), and some of these 
novel findings have already helped human medicine. For instance, the discovery of a 
hypocretin receptor 2 (HCRTR2) mutation in an autosomal recessive canine narcolepsy 
(Lin et al. 1999) has provided insights into the mechanism involved in human 
narcolepsies (Nishino et al. 2000), and contributed to the development of narcolepsy 
therapies (Hoyer & Jacobson 2013). Furthermore, dogs may be used to test gene therapy 
options, as has already been done with inherited eye diseases (Acland et al. 2001, 
Komaromy et al. 2010).  
The canine genome is organized into 38 pairs of autosomes and one pair of sex 
chromosomes (Switonski et al. 1996). The initial draft of the canine genome sequence 
was published in 2003 (Kirkness et al. 2003), which was followed by a high-quality 
genome assembly in 2005 (CanFam1.0 and CanFam2.0) (Lindblad-Toh et al. 2005). 
The current CanFam3.1 assembly was made available in 2011. Alongside the high-
quality genome sequence, a dense map of over 2.5 million single nucleotide 
polymorphisms (SNPs) was catalogued (Lindblad-Toh et al. 2005). This enabled the 
development of SNP arrays that can be utilized in genome-wide study approaches, such 
as linkage and association analyses. Importantly, the particular genomic architecture of 
dog breeds can be of use in genome-wide studies. The long-range LD within breeds 
makes it possible to map disease loci in genome-wide studies with only a limited 
number of samples and markers (Karlsson et al. 2007). However, on a downside, 
pinpointing the actual causative variant from the mapped locus may sometimes prove 
challenging because of the long haplotype blocks. Finally, recent advances in next-
generation sequencing technologies and the subsequent drop in their cost, has made it 
possible to use these techniques more routinely also in canine genetics. Exome 
sequencing and whole-genome sequencing can be used either independently or in 
parallel with association and linkage studies to identify disease-causing gene variants. 
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2.2 Inherited skeletal disorders affect bone and cartilage 
tissues 
Genetic skeletal disorders are diseases of the bone and cartilage tissues, arising from 
mutation in genes that govern skeletal patterning, development, growth and homeostasis 
(Warman et al. 2011). In humans, these disorders are individually rare but their 
collective birth prevalence is estimated to be around 1/5,000 (Orioli et al. 1986, 
Rasmussen et al. 1996). The most recent classification effort concerning human genetic 
skeletal diseases recognized altogether 456 distinct disease phenotypes that were placed 
into 40 different subcategories, depending on radiographic, biochemical and molecular 
features. For 316 of these disease entities, the molecular basis had been identified in 
altogether 226 different genes (Warman et al. 2011). Collectively, skeletal disorders are 
characterized by abnormalities in the shape, size and composition of the skeletal system. 
These changes can be either generalized or focal, and can vary greatly in severity 
(Mortier 2001, Superti-Furga et al. 2001). Disorders affecting individual bones, or a 
group of bones, have been called dysostoses, whereas generalized disorders of cartilage 
and bone have been referred to chondrodysplasias and osteodysplasias, respectively, or 
more generally as osteochondrodysplasias (Krakow & Rimoin 2010). Osteodysplasia is 
associated with reduced bone mineral density or excess bone deposition, and 
chondrodysplasia with cartilage defects, such as disturbed endochondral ossification 
(Newman & Wallis 2003). In addition to bone and cartilage defects, skeletal dysplasias 
can be accompanied by a variety of other clinical manifestations, such as auditory, 
neurologic, cardiac and ocular dysfunction (Krakow & Rimoin 2010). Although 
molecular information has now been incorporated into the categorization of human 
skeletal dysplasias, the naming of phenotypes has relied largely on different types of 
clinical and radiographic aspects. For instance, the terms rhizomelic, mesomelic and 
acromelic are used to refer to the involvement of the proximal, middle and distal limb 
segments, respectively, whereas ephiphyseal, metaphyseal, diaphyseal and spondylo 
(vertebral) determine the affected bone regions (Krakow & Rimoin 2010, Alanay & 
Lachman 2011). Another approach has been to use Greek terminology to define 
diseases such as thanatophoric (“death bringing”), campomelic (“bowing” of legs) and 
diastrophic (“twisting” of bones) dysplasia (Mortier 2001). Table 1 lists 
osteochondrodysplasia subclasses in humans and gives examples of disease phenotypes 
and disease-linked genes. 
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Table 1. Human osteochondrodysplasia subcategories and disease examples. 
Disease Group / Disease phenotype (OMIM#) Gene (Protein) 
?????????????????????????  
  Achondroplasia, AD (#100800)                                           FGFR3 (Fibroblast growth factor receptor 3) 
???????????????????????????  
  Spondyloepiphyseal dysplasia congenita, AD (#183900)   COL2A1 (Type II collagen) 
????????????????????????????  
  Stickler syndrome type 2, AD (#604841)                            COL11A1 (Type XI collagen) 
?????????????????????  
  Diastrophic dysplasia, AR (#222600)                                  SLC26A2 (Sulfate transporter) 
????????????????? 
  Dyssegmental dysplasia, AR (#224410)                             HSPG2 (Perlecan) 
????????????????  
  Spondyloepiphyseal dysplasia, AD (#612813)                   ACAN (Aggrecan) 
?????????- and related disorders  
  Frontometaphyseal dysplasia, XLD (#305602)                   FLNA (Filamin A) 
??TRPV4 group  
  Metatropic dysplasia, AD (#156530)                                  TRPV4 (Cation channel) 
??Short-ribs dysplasias group  
  Chondroectodermal dysplasia, AR (#225500)                    EVC1 (Ellis van Creveld protein) 
????????????????????????????????  
  Multiple epiphyseal dysplasia 1, AD (#132400)                  COMP (Cartilage oligomeric matrix protein) 
????????????????????????? 
  Cartilage-hair hypoplasia, AR (#250250)                            RMRP (RNA component of RNAse MRP) 
????????????????????????????????  
  Spondyloenchondrodysplasia, AR (#607944)                     ACP5 (Tartrate-resistant acid phosphatase) 
??????????-epi-(meta)-physeal dysplasias (SE(M)D)  
  SEMD, short limb-abnormal calcification, AR (#271665)    DDR2 (Discoidin domain receptor 2)  
??Severe spondylodysplastic dysplasias  
  Achondrogenesis type 1A, AR (#200600)                           TRIP11 (Golgi-microtubule-associated protein) 
??????????????????????  
  Acrocapitofemoral dysplasia, AR (#607778)                       IHH (Indian hedgehog) 
??????????????????????????  
  Chondrodysplasia, Grebe type, AR (#200700)                   GDF5 (Growth and differentiation factor 5) 
?????????????????????-mesomelic dysplasias  
  Dyschondrosteosis, pseudo-AD (#127300)                         SHOX (Short stature homeobox) 
???????????????????????  
  Campomelic dysplasia, AD (#114290)                                SOX9 (SRY-box 9) 
??Slender bone dysplasias  
  3-M syndrome, AR (#273750)                                             CUL7 (Cullin 7) 
??Dysplasias with multiple joint dislocations  
  Desbuquois dysplasia, AR (#251450)                                 CANT1 (Calcium-activated nucleotidase 1) 
?????????????????????????????????  
  Rhizomelic CDP type 1, AR (#215100)                               PEX7 (Peroxisomal biogenesis factor 7) 
??Neonatal osteosclerotic dysplasias  
  Chondrodysplasia, Blomstrand type, AR (#215045)           PTHR1 (PTH/PTHrP receptor 1) 
The table is modified from Warman et al. 2011. Abbreviations: AD = autosomal dominant; AR 
= autosomal recessive; XLD = X-linked dominant; XLR = X-linked recessive 
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2.2.1 Chondrodysplasias are caused by defects in endochondral 
ossification 
Intramembranous and endochondral ossification are the two principal mechanisms of 
bone formation. Intramembranous ossification transforms mesenchymal tissue directly 
into bone, whereas endochondral ossification occurs via a cartilaginous template 
(Newman & Wallis 2003, Krakow & Rimoin 2010). Endochondral ossification is the 
major mechanism responsible for longitudinal bone growth and its dysfunction typically 
results in disproportionate short stature (Newman & Wallis 2003). Endochondral 
ossification takes place at the cartilaginous growth plates (also known as physes and 
ephiphyseal plates), which are located at the ends of the growing long bones, between 
the epiphysis and metaphysis (Fig. 2A). The growth plates are composed of 
extracellular matrix (ECM) and longitudinally stacked chondrocyte columns, which can 
be divided into morphologically distinct chondrocyte zones based on the functional 
states of the cells (Fig. 2B) (Mackie et al. 2008). Within the growth plate, the 
chondrocytes first proliferate and then differentiate into large, non-dividing, 
hypertrophic cells that eventually die and become replaced by bone tissue (Fig. 2B) 
(Yeung Tsang et al. 2014). The chondrocytes also deposit the surrounding ECM, which 
is composed of collagens, proteoglygans and other structural proteins (Myllyharju 
2014). However, the components of the growth plate ECM have not only structural 
importance, but can also mediate important functional signals via cell surface receptors 
(Mackie et al. 2008). Overall, the increase in bone length is thought to be the combined 
result of chondrocyte division, hypertrophy and matrix synthesis (Wilsman et al. 1996). 
The conversion of cartilage to bone is governed by several different transcription 
factors, growth factors and cell surface receptors that mediated signaling cascades 
related to growth plate physiology (Myllyharju 2014). Not surprisingly, many 
chondrodysplasias are caused by defects either in ECM components or in proteins that 
govern chondrocytic differentiation and proliferation (Table 1).  
SOX9 transcription factor, Indian hedgehog (IHH), parathyroid hormone-related 
protein (PTHrP) and fibroblast growth factor receptor 3 (FGFR3) are examples of 
proteins that control the chondrocyte journey within the growth plate. SOX9 is needed 
for the differentiation of mesenchymal cells into chondrocytes, and in the zone of 
chondrocyte proliferation, it regulates the expression of several genes important for 
growth plate function, such as type II collagen (Bell et al. 1997, Bi et al. 1999). 
Heterozygous SOX9 mutations cause campomelic dysplasia, which is a severe and often 
lethal disorder, characterized by congenitally bowed, thick long bones and XY sex 
reversal (Foster et al. 1994, Wagner et al. 1994). Once the chondrocytes mature and 
enter the prehypertrophic stage IHH and PTHrP form a negative feedback loop that 
tightly regulates chondrocyte differentiation and prevents premature hypertrophy 
(Vortkamp et al. 1996). IHH mutations cause autosomal recessive short-stature 
dysplasia known as acrocapitofemoral dysplasia (Hellemans et al. 2003) and 
dominantly inherited type A1 brachydactyly, characterized by short or absent middle 
phalanges (Kirkpatrick et al. 2003). The parathyroid hormone receptor 1 (PTH1R) 
serves as a receptor for both parathyroid hormone and PTHrP. Heterozygous PTH1R 
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mutations cause Jansen metaphyseal chondrodysplasia (Schipani et al. 1995), whereas 
homozygous PTH1R mutations result in two other types of skeletal dysplasia, 
Blomstrand chondrodysplasia (Jobert et al. 1998) and Eiken syndrome (Duchatelet et al. 
2005).  
 
 
Figure 2. The growth plate. A) The epiphyseal growth plates are found in the ends of long 
bones and are responsible for bone growth. B) Within the growth plate, the 
chondrocytes are organized in longitudinal columns, and can be separated into 
different horizontal zones that reflect the cellular states. The reserve zone contains 
resting chondrocytes. In the zone of proliferation, the chondrocytes form distinctive 
stacks of rapidly-dividing flattened cells. Once the chondrocytes enter the 
prehypertrophic zone, they exit the cell cycle and initiate differentiation. In the 
hypertrophic zone, the chondrocytes become massively enlarged and eventually 
die. Finally, the growth plate cartilage is calcified and replaced by bone tissue, 
through the invasion of blood vessels, osteoclasts and osteoblasts. The figure is 
adapted from Mackie et al. 2008 and Yeung Tsang et al. 2014. Image sources: 
Radiograph, the lower leg of a 12-year-old child (Wikimedia commons, Gilo1969); 
Growth plate histology, rabbit, Masson-Goldner trichrome stain (Wikimedia 
commons, Jeppe Achton Nielsen). 
FGFR3 is a negative regulator of growth plate chondrocyte proliferation and 
differentiation (Deng et al. 1996). The most frequent and well-known form of short-
limbed dwarfism, achondroplasia, is caused by heterozygous FGFR3 mutations (Shiang 
et al. 1994, Rousseau et al. 1994). The condition is characterized by rhizomelic 
shortening of limbs and particular facial features, including prominent forehead and 
mid-face hypoplasia (Horton et al. 2007). The large majority of achondroplasia cases 
result from de novo mutations, which typically are of paternal origin and associated 
with advanced paternal age (Wilkin et al. 1998). Achondroplasia mutations are thought 
Review of the literature 
 
 
 
 
20 
to cause abnormal FGFR3 activation, which results in exaggerated inhibition of bone 
growth (Horton et al. 2007). In addition to achondroplasia, FGFR3 mutations cause a 
spectrum of other skeletal disorders, such as thanatophoric dysplasia, which is a severe 
short-limbed dysplasia that typically leads to death at the perinatal period (Tavormina et 
al. 1995).  
The integrity of the growth plate matrix can be compromised through mutations in 
ECM proteins, but also via other pathogenic mechanisms, such as disturbed ECM 
remodeling. Collagens constitute a key component of cartilage ECM. The major 
collagen in growth plate cartilage is type II collagen but collagens IX, X and XI are also 
present (Mendler et al. 1989, Myllyharju 2014). Type II collagen is encoded by the 
COL2A1 gene, which is defective in a range of autosomal dominant skeletal disorders 
(Kannu et al. 2012) that vary from mild disorders of the adulthood, such as premature 
osteoarthritis (Ala-Kokko et al. 1990), to more severe short-stature dysplasias and 
perinatally lethal syndromes, such as Strudwick type spondyloepimetaphyseal dysplasia 
(Tiller et al. 1995) and achondrogenesis type II (Vissing et al. 1989), respectively. In 
addition to collagen type II disorders, various skeletal dysplasia are caused by mutations 
in the type IX, X and XI collagen genes, and also by mutations in other ECM proteins, 
such as cartilage oligomeric matrix protein (COMP) and proteoglycans aggrecan and 
perlecan (Warman et al. 2011). The matrix metalloproteinases MMP9 and MMP13 
work together in degrading type II collagen and aggregan within growth plate ECM, 
allowing subsequent vascular invasion and ossification (Stickens et al. 2004). MMP9 
and MMP13 mutations cause metaphyseal anadysplasia, which is a type of 
chondrodysplasia characterized by short-stature and severe metaphyseal bone 
irregularities that typically resolve in early childhood (Lausch et al. 2009, Li et al. 
2015). A subgroup of skeletal dysplasias result from impaired sulfation of ECM 
proteoglycans. The SLC26A2 gene encodes a sulfate transporter that maintains adequate 
chondrocyte sulfate levels, which are required for proteoglycan sulfation (Park et al. 
2014). Similar to many other skeletal dysplasia genes, mutations in SLC26A1 cause a 
spectrum of phenotypes (Hästbacka et al. 1994, Superti-Furga et al. 1996, Superti-Furga 
et al. 1999), ranging from lethal achondrogenesis (Superti-Furga et al. 1996) to a mild 
form of epiphyseal dysplasia (Superti-Furga et al. 1999). 
2.2.2 Inherited chondrodysplasia in dogs 
Chondrodysplastic phenotype can occur in dogs either as a desired, breed-defining 
characteristic (Martinez et al. 2007, Parker et al. 2009), or as an unwanted condition in 
otherwise non-chondrodysplastic breeds (Carrig et al. 1977, Bingel & Sande 1982, 
Sande et al. 1982, Breur et al. 1989). Similar to humans, canine chondrodysplasias are 
characterized by disproportionate short-limbed dwarfism. In many cases, asynchronous 
growth of the radius and ulna results in curved front limbs and carpal valgus deformity 
(bending and outward rotation of the distal limbs). Other clinical features may include 
bone malformations, vertebrate abnormalities, joint defects and secondary osteoarthritis 
(Sande & Bingel 1983). Overall, the clinical phenotype can vary from a mild shortening 
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of long bones (Frischknecht et al. 2013) to a more severe skeletal deformity and 
lameness (Riser et al. 1980, Neff et al. 2012). Flaring, widening or otherwise irregular 
appearance of epiphyses, growth plates and metaphyses are often seen in radiographic 
examination (Sande et al. 1982, Bingel & Sande 1982, Breur et al. 1989, Bingel & 
Sande 1994, Martinez et al. 2007). Histological characteristics vary depending on the 
disorder, but can include abnormal structure of forming metaphyseal bone and different 
types of growth plate disturbances, such as disorganized chondrocyte columns, 
abnormal chondrocyte appearance, reduced chondrocyte numbers and abnormal wide 
bars of ECM (Sande et al. 1982, Bingel & Sande 1982, Breur et al. 1989, Bingel & 
Sande 1994, Martinez et al. 2007).  
The molecular genetic background of five canine chondrodysplasias has been 
delineated thus far (Table 2). The first genetic discovery shed light into an autosomal 
dominant breed-defining chondrodysplasia, fixed into breeds such as the Dachshund, 
Basset Hound, Pekingese and Corgi (Martinez et al. 2007, Parker et al. 2009). By using 
a multi-breed genome-wide association approach, the phenotype was associated with an 
expressed extra copy of fibroblast growth factor 4 (FGF4) gene that was found to be 
inserted within a long interspersed element (LINE) (Parker et al. 2009). The expression 
of the FGF4 retrogene was suggested to cause an abnormal activation of fibroblast 
growth factor receptors, such as FGFR3. In all affected breeds, a common haplotype 
surrounded the retrogene, indicating that the retrotransposition event had occurred only 
once before the modern breeds were created (Parker et al. 2009).  
The four other genetically characterized canine chondrodysplasias are autosomal 
recessive conditions. The Samoyed and Labrador Retriever breeds are both affected 
with a very similar type of oculo-skeletal dysplasia, characterized by short-limbed 
dwarfism and severe ocular defects, such as cataracts and retinal detachment (Carrig et 
al. 1977, Meyers et al. 1983, Aroch et al. 1996). These disorders were found to be 
caused by homozygous defects in the type IX collagen genes, COL9A2 and COL9A3 
(Goldstein et al. 2010). Homozygous mutations in the human COL9A2 gene result in 
Stickler syndrome type V, which resembles the canine phenotype, as it is also 
characterized by ocular abnormalities and short stature (Baker et al. 2011). Another type 
of chondrodysplasia that affects the Labrador Retriever breed causes only a mild 
shortening of long bones (Frischknecht et al. 2013). The phenotype is associated with a 
homozygous missense mutation in the type XI collagen gene, COL11A2 (Frischknecht 
et al. 2013), which is also linked with several human skeletal phenotypes (Table 2) 
(Vikkula et al. 1995). Finally, a severe form of osteochondrodysplasia in the Miniature 
Poodle breed is caused by a 130-kb homozygous deletion in the SLC13A1 gene, 
encoding a sodium/sulfate symporter that regulates serum sulfate levels (Neff et al. 
2012). The affected dogs present with several skeletal defects, such as short and curved 
long bones, malformed femoral heads and necks, misshapen paws and a flattened rib 
cage (Riser et al. 1980). Similar to the human SLC26A2-linked dysplasias, the canine 
phenotype was suggested to result from disturbed sulfation of ECM proteoglycans (Neff 
et al. 2012). Besides these genetically characterized conditions, several other canine 
osteochondrodysplasias with an unknown genetic cause have been described (Table 3). 
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Table 2. Canine chondrodysplasias with an identified genetic basis. 
Affected 
????? 
Clinical  
features 
Radiographic/ 
histologic features 
Gene 
Protein 
Human skeletal 
disease (OMIM#) 
Labrador  
Retriever 
Short-limbed 
dwarfism, bowing  
of front limbs,  
carpal valgus, 
ocular defects 
Curved radii,  
ununited anconeal  
and coronoid 
processes, hip 
dysplasia,  
delayed development 
of epiphyses  
(Carrig et al. 1977) 
COL9A3 
Type IX collagen 
?Multiple epiphyseal 
dysplasia 3 (#600969) 
 
Labrador  
Retriever 
Mild short-limbed 
dwarfism  
Slightly shortened  
long bones,  
widened epiphyses 
(Frischknecht  
et al. 2013) 
COL11A2 
Type XI collagen 
?Fibrochondrogenesis 2 
(#614524) 
?Otospondylomega-
epiphyseal dysplasia 
(#215150)  
?Stickler syndrome III 
(#184840) 
?Weissenbacher-
Zweymuller syndrome 
(#277610) 
Miniature  
Poodle 
Short-limbed 
dwarfism, bowed 
limbs, enlarged 
joints, flattened rib 
cage, lameness, 
secondary arthritis 
Short vertebral bodies, 
maformed ribs, stippled 
and poorly outlined 
epiphyses, abnormal 
hyaline cartilage, 
delayed ossification 
(Riser et al. 1980) 
SLC13A1 
Sodium/ 
sulfate symporter 
Not reported 
Samoyed 
Short-limbed 
dwarfism, carpal 
valgus, ocular 
defects  
Metaphyseal flaring; 
curved radii; abnormal 
femoral heads  
(Meyers et al. 1983, 
Aroch et al. 1996) 
COL9A2 
Type IX collagen 
?Multiple epiphyseal 
dysplasia 2 (#600204) 
?Stickler Syndrome V 
(#614284) 
Several short-
stature breeds 
(Dachshund, 
Gorgi, Basset 
Hound etc.) 
Breed defining 
short-stature 
dwarfism,  
bowed limbs 
Wide metaphyses, 
irregular epiphyses, 
disorganized 
chondrocyte columns, 
premature ossification 
(Martinez et al. 2007) 
FGF4 
Fibroblast growth 
factor 4 
Not reported 
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???????? Canine chondrodysplasias with an unknown genetic etiology. 
Affected 
????? 
Clinical 
features 
Radiographic/ 
histologic features 
Similar human 
disease 
Alaskan 
Malamute 
Short-limbed 
dwarfism, bowing of 
limbs, carpal valgus, 
anemia 
Flared, wide and irregular growth 
plates, excess growth plate matrix, 
metaphyseal microfractures  
(Smart & Fletch 1971,  
Sande et al. 1982) 
?Metaphyseal 
dysplasia 
Danish-Swedish 
Farm Hound 
Short-limbed 
dwarfism, abnormally 
short limbs and body, 
lameness 
Short vertebral bodies, abnormal 
vertebral epiphyses, narrow articular 
spaces, spondylosis, osteoarthritis 
of joints (Arnbjerg et al. 2007) 
?X-linked spondylo-
epiphyseal dysplasia 
tarda 
English  
Pointer 
Short-limbed 
dwarfism, bowed 
limbs, flattened 
sternum, enlarged 
growth plates, 
lameness 
Flared and wide growth plates, 
widened zone of chondrocyte 
hypertrophy, degeneration of 
articular cartilage  
(Whitbread et al. 1983) 
Not available 
 
Great  
Pyrenees  
Short-limbed 
dwarfism,  
deafness 
Short ribs, abnormal vertebrae, wide 
metaphyses, dizorganization of 
chondrocyte columns and wide 
areas of matrix, thick and irregular 
trabeculae in spongiosa  
(Bingel & Sande 1994) 
?Spondylometa-
physeal dysplasia 
 
Irish Setter 
Short-limbed 
dwarfism,  
bowing of front  
limbs 
Shortened vertebral bodies,  
subtle histological abnormalities  
in epiphyses, growth plates and 
spongiosa (Hanssen et al. 1998) 
?Hypochondroplasia 
 
Labrador 
Retriever 
Short-limbed 
dwarfism,  
bowed front limbs 
Absence of the anconeal process, 
wide metaphyses, disorganized 
growth plate chondrocyte columns 
(Smit et al. 2011) 
?Multiple epiphyseal 
dysplasia  
?Spondylo-epiphyseal 
dysplasia congenital 
?Stickler syndrome 
Norwegian 
Elkhound 
Short-limbed 
disproportionate 
dwarfism, bowing of 
limbs, carpal valgus 
Flared and wide growth plates, 
delayed ossification of carpal cuboid 
bones, short vertebral bodies, 
abnormal chondrocyte morphology, 
disorganization of chondrocyte 
columns (Bingel & Sande 1982) 
?Spondylometa-
physeal dysplasia 
Scottish 
Deerhound 
Short-limbed 
disproportionate 
dwarfism, bowing of 
limbs, joint laxity, 
exercise intolerance 
Short vertebrae,  
abnormal carpal and tarsal bones,  
malformed hip and elbow joints, 
histological irregularities in 
epiphyses, growth plates and 
metaphyses (Breur et al. 1989) 
?Spondyloepimeta-
physeal dysplasia 
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????Inherited neurodegenerative diseases 
Neurodegenerative disorders encompass a variety of conditions, in which the primary 
characteristic is progressive neuronal degeneration that has irreversible and debilitating 
effects on motor and cognitive functions (Przedborski et al. 2003). Certain 
neurodegenerative diseases can occur without a clear family history, such as sporadic 
forms of Alzheimer disease (AD), Parkinson disease (PD) and amyotrophic lateral 
sclerosis (ALS) (Mitsui & Tsuji 2014), whereas others are inherited in a monogenic 
fashion, including the cerebellar ataxias (Mancuso et al. 2014), Huntington disease 
(HD) (The Huntington's Disease Collaborative Research Group 1993) and familial ALS 
(Rosen 1993), AD (Goate et al. 1991) and PD (Polymeropoulos et al. 1997). Depending 
on the disorder, the principal neurodegenerative lesions are characteristically found in 
selected neuronal subpopulations within specific anatomical regions of the nervous 
system, giving rise to a particular set of neurological symptoms (Hardy & Gwinn-Hardy 
1998, Przedborski et al. 2003). For instance, the inherited ataxias are characterized by 
cerebellar degeneration (Manto & Marmolino 2009), ALS by lower and upper motor 
neuron loss (Foerster et al. 2013) and PD by atrophy of the substantia nigra (Dickson et 
al. 2009). However, despite these distinctions, there can be significant overlap between 
the clinical signs and the affected nervous system regions, which can make diagnosis 
challenging. When the disease manifests clinically, marked pathological lesions are 
usually already present (Hardy & Gwinn-Hardy 1998, Przedborski et al. 2003).  
??????Protein homeostasis and degradative pathways in 
neurodegeneration 
Regardless of the underlying genetic defects or risk factors, common molecular 
cascades have emerged both in familial and complex neurodegenerative disorders 
(Jellinger 2010). These include disturbances in protein homeostasis (proteostasis) (Lim 
& Yue 2015), mitochondrial dysfunction and oxidative stress (Federico et al. 2012, 
Dasuri et al. 2013), altered calcium signaling (Marambaud et al. 2009) and endoplasmic 
reticulum stress (Hetz & Mollereau 2014). A recurrent finding in many 
neurodegenerative diseases is the accumulation of proteinaceous aggregates within the 
nervous system. For example, PD is characterized by α-synuclein aggregation (Lewy 
bodies), AD by deposition of β-amyloid (senile plaques) and tau (neurofibrillary 
tangles), and HD by aggregation of the mutated huntingtin protein (Forman et al. 2004, 
Lim & Yue 2015). Certain causative mutations, such as coding polyglutamine (polyQ) 
repeat expansions, directly result in aberrant and aggregation-prone protein structures 
(Weber et al. 2014). However, neuronal proteostasis may also be disturbed through 
dysfunction of the pathways that are involved in protein trafficking, degradation and 
quality control.  
The autophagy-lysosome route and the ubiquitin-proteasome system (UPS) are the 
two major intracellular proteolytic mechanisms that are involved in maintaining cellular 
homeostasis under basal and stressful conditions (Fig. 3) (Nedelsky et al. 2008). The 
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UPS has been implicated to selectively target short-lived and misfolded proteins, which 
are first polyubiquitinated by E3 ubiquitin ligases, and then degraded via the 
proteasome complex (Korolchuk et al. 2010). The UPS pathway is closely linked with 
the molecular chaperones and the endoplasmic reticulum (ER) -associated protein 
degradation (ERAD) machinery. The chaperone proteins function in ensuring correct 
protein folding and recognizing misfolded protein states (Smith et al. 2015), while the 
ERAD machinery delivers aberrantly folded proteins from the ER to the cytosolic 
proteasome machinery (Smith et al. 2011). In comparison to the UPS, the autophagy 
pathway is thought to constitute more of a bulk degradation and recycling system, 
targeting organelles, as well as long-lived and aggregated proteins (Korolchuk et al. 
2010). Macroautophagy, which is the major autophagy pathway and usually referred to 
simply as autophagy, engulfs its targets inside the double-membraned autophagic 
vesicles, autophagosomes (Fig. 3). The autophagosomes then fuse with the lysosomes, 
enabling the degradation of the captured materials via lysosomal hydrolases (Hyttinen et 
al. 2013). The endocytic trafficking pathways also deliver material for lysosomal 
degradation. Late endosomes that carry degradation-bound materials fuse with 
lysosomes, either directly or through intermediate vesicular structures, amphisomes, 
which are the fusion products of endosomes and autophagosomes (Fig. 3) (Berg et al. 
1998).  
As a whole, neurons appear to be very sensitive to perpetuations in catabolic 
pathways and increasing evidence suggests that these intertwined degradative routes are 
either directly disturbed or otherwise affected in a range of neurodegenerative diseases 
(Lehman 2009, Nixon 2013, Dantuma & Bott 2014, Wong & Holzbaur 2015). For 
instance, several forms of familial PD result from mutations that disrupt protein 
trafficking and degradation through the endosomal pathway (Perrett et al. 2015). 
Dysfunction of molecular chaperones causes inherited cerebellar ataxia (Engert et al. 
2000, Anttonen et al. 2005, Senderek et al. 2005, Shi et al. 2013), and defects in 
autophagy-linked receptor proteins have been implicated in familial ALS (Majcher et al. 
2015). 
The lysosome is the end-point of several degradation routes, it is not therefore 
surprising that primary lysosomal defects also cause neurodegeneration. Lysosomal 
dysfunction gives rise to a specific disease entity known as lysosomal storage disorders 
(LSDs). LSDs are typically caused by loss-of-function mutations in lysosomal enzymes, 
leading to an excessive accumulation of their unprocessed substrates within storage 
vacuoles (Boustany 2013). The majority of LSDs involve the nervous system (Boland & 
Platt 2015), in particular the neuronal ceroid lipofuscinoses (NCLs), which are 
characterized by neurodegeneration (Bennett & Rakheja 2013). Interestingly, most 
NCLs do not result from defects in lysosomal enzymes, but are linked to genes that 
function within vesicular trafficking pathways, related to the ER, Golgi, endosome and 
autophagy-lysosome axis (Bennett & Rakheja 2013, Kollmann et al. 2013). 
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????????? Cellular degradative pathways. The two principal degradative pathways are the 
ubiquitin-proteasome system (UPS) and the autophagy-lysosome route. The UPS 
can receive target proteins from the endoplasmic reticulum, where molecular 
chaperones recognize misfolded proteins. The misfolded or unfolded proteins are 
then ubiquitinated through the actions of the E1, E2 and E3 enzymes, which 
function canonically in ubiquitin activation, conjugation and ligation, respectively. 
Polyubiquitination targets proteins for the proteasome, but may also serve as an 
autophagosomal signal. The macroautophagy pathway captures degradation-
bound materials within autophagosomal vesicles that eventually fuse with the 
lysosomes, either directly, or alternatively via formation of amphisomes that are 
fusion products of late endosomes (also known as multivesicular bodies, MVBs). 
The figure is adapted from Nedelsky et al. 2008 and Lim & Yue 2015. 
??????Inherited ataxias are caused by cerebellar dysfunction 
Inherited cerebellar ataxias are rare neurological diseases that result from degeneration 
and dysfunction of the cerebellum and its connections. The predominant clinical sign is 
progressive ataxia, but other neuronal and extraneuronal tissues may also show various 
degrees of involvement (Manto & Marmolino 2009, Klockgether & Paulson 2011, 
Mancuso et al. 2014). Ataxia itself is a neurological symptom of motor incoordination, 
which typically manifests as impaired gait, caused by difficulty in coordinating limb 
movements. In addition to gait difficulties, cerebellar dysfunction typically causes 
tremors, balance problems, poor posture, abnormal eye movements and speech 
difficulties. Patients that suffer from cerebellar dysfunction may also suffer from mild 
cognitive deficits (Schmahmann 2004, Grimaldi & Manto 2012).  
The cerebellum is an anatomically distinct region at the back of the brain (Fig. 
4A-B). Besides its well-established role in motor coordination, increasing evidence 
suggests involvement in cognitive functions, such as those relating to working memory 
and language (Ramnani 2006, Gordon 2007, Stoodley 2012). The gross cerebellar 
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anatomy can vary considerably between different animal species but the cellular 
architecture and circuitry are largely conserved in evolution (Voogd & Glickstein 1998). 
The tightly-folded cerebellar cortex has a uniform composition of three different cell 
layers: the molecular layer, the Purkinje cell (PC) layer and the granular cell layer (Fig. 
4C). The PCs are considered the most important information-processing units within the 
cerebellar cortex. They provide the sole output of the cortex by synapsing with the deep 
cerebellar nuclei and certain brain stem nuclei (Voogd & Glickstein 1998, Ramnani 
2006). Inherited cerebellar ataxias typically result from PC loss. As the main functional 
units of the cerebellar cortex, the PCs are very sensitive to different types of 
disturbances affecting the cerebellum (Grüsser-Cornehls & Bäurle 2001). At the same 
time, PC loss and dysfunction can cause secondary degeneration of other cerebellar 
neurons, such as the granule cells and the deep cerebellar nuclei (Sarna & Hawkes 
2003).  
The human inherited ataxias have a highly heterogeneous disease etiology and 
clinico-pathological characteristics (Pandolfo & Manto 2013). Most hereditary ataxias 
in humans are autosomal dominant or recessive diseases, while a few are inherited in an 
X-linked manner. In general, the dominant ataxias tend to be restricted to the central 
nervous system (CNS) and have an onset in adulthood, whereas the recessive ataxias 
can involve multiple organs and typically have an earlier onset (Taroni & DiDonato 
2004, Wolf & Koenig 2013). The autosomal dominant ataxias have been systematically 
designated as spinocerebellar ataxias (SCAs), and currently include at least 35 different 
disease phenotypes, with a molecular genetic cause identified for the large majority 
(Kim & Cho 2015) (http://neuromuscular.wustl.edu/ataxia/domatax.html). In 
comparison to the dominant ataxias, the autosomal recessive ataxias represent a less 
well-defined disease entity that can include anywhere from 20 to well over 50 disorders, 
depending on the classification criteria (Mancuso et al. 2014, Kim & Cho 2015) 
(http://neuromuscular. wustl.edu/ataxia/recatax.html). 
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Figure 4. The cerebellum and its cellular composition. A) The human and B) canine brain, 
with arrows denoting the cerebellum. The major anatomical subdivisions within 
the cerebellum include the vermis and the cerebellar hemispheres. C) The 
cerebellar cortex is composed of three distinct layers: the molecular layer, 
Purkinje cell (PC) layer and granular cell layer. The molecular layer is relatively 
cell poor, whereas the small granule cells within granule cell layer are the most 
numerous neuron type within the whole brain. The somas of the large PCs form a 
monolayer between the molecular and granular cell layers and their intricate 
dendritic trees extend to the molecular layer. The PC dendrites synapse with two 
major afferents, the climbing fibers, which originate from the inferior olive, and 
mossy fibers, which originate from the peripheral nervous system, spinal cord and 
brainstem. The climbing fibers synapse directly with the PC dendrites, whereas the 
mossy fibers pass information through the excitatory granule cells, whose axons 
constitute the parallel fibers (Ito 2006). Other cell types within the cortex include 
the Golgi-, stellate- and basket cells, which are inhibitory interneurons (Voogd & 
Glickstein 1998). The schematic structure of the cerebellar cortex is adapted from 
Ramnani 2006. Image sources: Human brain (Wikimedia Commons, Popular 
Science Monthly Volume 1); Canine brain (Pixabay, Katja); PC image (Wikimedia 
Commons, http://ccdb.ucsd.edu); Cerebellar cortex histology, dog, HE (Pernilla 
Syrjä). 
 
 
 
 
29 
The genetic background of the dominantly inherited SCAs includes expansion of both 
coding and non-coding microsatellites, as well as more conventional mutations 
(Hekman & Gomez 2015). Several SCAs are polyQ diseases, caused by expanded 
glutamine-codon (CAG) repeats within protein coding regions of the disease-linked 
genes (Fan et al. 2014). Translation of the polyQ tracts is thought to disrupt protein 
folding, which eventually results in accumulation and aggregation of the aberrant 
polypeptides. It is currently not clear whether the large end-point aggregates are the 
primary cause of neuronal death, or if their formation is a protective mechanisms to help 
cells cope with smaller soluble oligomers that may be toxic for the cell (Takahashi et al. 
2010, Todd & Lim 2013). The expanded CAG-repeats are unstable and tend to expand 
further, resulting in anticipation, which refers to a more severe disease with an earlier 
onset in successive generations (Fan et al. 2014). At the moment, coding CAG-repeat 
expansions have been reported in six SCAs (SCAs 1, 2, 3, 6, 7 and 17) (Orr et al. 1993, 
Kawaguchi et al. 1994, Pulst et al. 1996, Lindblad et al. 1996, Zhuchenko et al. 1997, 
Koide et al. 1999), whereas untranslated repeat expansions are found in five diseases 
(SCAs 8, 10, 12, 31 and 36) (Koob et al. 1999, Holmes et al. 1999, Matsuura et al. 
2000, Sato et al. 2009, Kobayashi et al. 2011). The pathogenic effects of the non-coding 
repeat expansions have been implicated to include both RNA and protein level toxicity 
(Moseley et al. 2006, Daughters et al. 2009, Zu et al. 2011, White et al. 2012, Niimi et 
al. 2013). The causative mutation is reported for at least 16 SCAs that do not result 
from repeat expansions (http://neuromuscular.wustl.edu/ataxia/domatax.html). The 
pathogenic mechanisms in these diseases include mitochondrial dysfunction (SCA28) 
(Di Bella et al. 2010) and ion channel disturbances (SCAs 13, 19/22, 27, 41) (van 
Swieten et al. 2003, Waters et al. 2006, Duarri et al. 2012, Lee et al. 2012, Tempia et 
al. 2015, Fogel et al. 2015).  
The recessive ataxias include diseases with various etiologies, such as mitochondrial 
dysfunction, impaired DNA repair, metabolic disease and molecular chaperone 
dysfunction (Table 4) (De Michele et al. 2004, Vermeer et al. 2011). The autosomal 
recessive Friedreich ataxia (FRDA) is estimated to be the most common form of 
inherited ataxia in Caucasian populations (Cossee et al. 1997, Schulz et al. 2009). The 
large majority of FRDA cases are caused by a homozygous GAA-triplet expansion in 
the first intron of the frataxin (FXN) gene, resulting in reduced RNA and protein levels 
(Campuzano et al. 1996, Campuzano et al. 1997). The frataxin protein localizes to the 
mitochondria (Campuzano et al. 1997), and may have roles in iron homeostasis, 
respiratory control and oxidative stress resistance (Wong et al. 1999, Delatycki et al. 
1999, Lodi et al. 1999). In addition to early-onset ataxia, FRDA patients typically suffer 
from cardiomyopathy, diabetes and scoliosis (Parkinson et al. 2013). Ataxia-
telangiectasia and ataxia-telangiectasia-like disorder 1 represent recessive ataxias 
resulting from defective DNA repair. The diseases are caused by mutations in the 
double-strand break repair genes ATM (Savitsky et al. 1995) and MRE11 (Stewart et al. 
1999), respectively. In both conditions, cerebellar ataxia is accompanied by 
chromosomal instability and immune deficiency, while ataxia-telangiectasia patients 
also present with cancer susceptibility and small dilated blood vessels (telangiectases) 
(Taylor et al. 2004). Molecular chaperone  dysfunction has been implicated  for instance 
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Table 4. Autosomal recessive human ataxias and disease genes1.  
Disease (OMIM#) Gene Protein 
??DNA repair defects 
 Ataxia-telangiectasia (#208900) ATM Serine/threonine kinase 
 Ataxia-telangiectasia-like disorder 1 (#604391) MRE11A Double strand break repair nuclease 
 Ataxia-telangiectasia-like disorder 2 (#615919) PCNA Proliferating cell nuclear antigen 
 Ataxia-oculomotor apraxia 1 (#208920) APTX Aprataxin 
Ataxia-oculomotor apraxia 2 (#606002) SETX Senataxin 
 Ataxia-oculomotor apraxia 4 (#616267) PNKP Polynucleotide kinase 3'-phosphatase 
 Spinocerebellar ataxia with axonal neuropathy 1 
(#607250) 
TDP1 Tyrosyl-DNA phosphodiesterase 1 
??Mitochondrial dysfunction 
 Friedrich ataxia (#229300) FXN Frataxin 
 Infantile-onset spinocerebellar ataxia (#271245) C10orf2 DNA helicase (Twinkle) 
Mitochondrial recessive ataxia syndrome (#607459) POLG Polymerase gamma 
 Primary coenzyme Q10 deficiency 4 (#612016) ADCK3 AarF domain containing kinase  
 ??Metabolic ataxias 
 Abetalipoproteinaemia (#200100) MTP Microsomal triacylglycerol transfer protein 
Ataxia with isolated vitamin E deficiency (#277460) TTPA Alpha-tocopherol transfer protein 
??Chaperone defects 
Spastic ataxia of Charlevoix- Saguenay (#270550) SACS Sacsin molecular chaperone 
 Marinesco-Sjögren syndrome (#248800) SIL1 Nucleotide exchange factor 
 SCAR16 (#615768) STUB1 Ubiquitin ligase/co-chaperone 
??Congenital ataxias 
 Cayman ataxia (#601238) ATCAY Caytaxin 
 SCAR5 (#606937) ZNF592 Zinc finger protein 592 
 SCAR13 (#614831) GRM1 Metabotropic glutamate receptor 1 
 SCAR17 (#616127) CWF19L1 CWF19-like 1, cell cycle control 
??????????l-lysosomal dysfunction 
 SCAR7 (#609270) TPP1 Tripeptidyl peptidase I 
 SCAR15 (#615705) KIAA0226 Rubicon 
 SCAR20 (#616354) SNX14 Sorting nexin 14 
??Other recessive ataxias 
 Ataxia-oculomotor apraxia 3 (#615217) PIK3R5 Phosphoinositide-3-kinase, subunit 5 
 SCAR8 (#610743) SYNE1 Synaptic nuclear envelope protein 1 
 SCAR10 (#613728) ANO10 Anoctamin 10  
 SCAR11 (#614229) SYT14 Synaptotagmin XIV 
 SCAR14 (#615386) SPTBN2 β-III spectrin 
 SCAR18 (#616204) GRID2 Ionotropic glutamate receptor 
 Lichtenstein-Knorr syndrome (#616291) SLC9A1 Na+/H+ antiporter 
1The list does not include all known recessive ataxia syndromes.  
Abbreviations: SCAR = spinocerebellar ataxia, autosomal recessive 
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in Marinesco-Sjögren syndrome, which is an ataxia syndrome characterized by 
cerebellar atrophy, cataracts and myopathy. The disease is caused by mutations in the 
co-chaperone gene SIL1 (Anttonen et al. 2005, Senderek et al. 2005). SIL1 is a 
nucleotide exchange factor that functions as a co-chaperone for BiP (HSP70) (Chung et 
al. 2002), which in turn promotes protein folding and assembly within the ER, and 
targets misfolded proteins for proteasomal degradation (Otero et al. 2010). 
In recent years, several novel recessive ataxia genes have been identified, largely by 
utilizing next-generation sequencing methods. The resulting phenotypes are referred to 
as SCARs (spinocerebellar ataxia, autosomal recessive) (Table 4). Although the exact 
pathological mechanisms remain to be delineated for many of the conditions, some 
interesting links to the degradative pathways have emerged. The new disease-associated 
genes include the co-chaperone/E3 ligase STUB1 (Shi et al. 2013), as well as the sortin 
nexin gene SNX14 (Akizu et al. 2015) and KIAA0226, which encodes the rubicon 
protein (Assoum et al. 2010, Assoum et al. 2013). Both sortin nexin-14 and rubicon 
localize to endosomes and lysosomes and have been indicated to function in autophagy 
regulation (Matsunaga et al. 2009, Zhong et al. 2009, Akizu et al. 2015). Ataxia-
causing mutations were also found in the lysosomal enzyme gene tripeptidyl peptidase 1 
(TPP1) (Sun et al. 2013). TPP1 mutations have been previously reported in late-
infantile NCL (Sleat et al. 1997), and the new link to cerebellar ataxia implicates shared 
genetic etiology in these different types of neurodegenerative diseases. 
???.2. Inherited cerebellar ataxia in dogs 
Inherited cerebellar ataxia occurs in several dog breeds. Both spinocerebellar (Higgins 
et al. 1998, Gilliam et al. 2014) and pure cerebellar disorders (Steinberg et al. 1981, 
Yasuba et al. 1988, Gandini et al. 2005) have been described, along with some more 
systemic diseases (deLahunta & Averill 1976, Chieffo et al. 1994, Carmichael et al. 
1996). In veterinary medicine, degeneration of the cerebellar cortex has traditionally 
been referred to as cerebellar cortical abiotrophy (de Lahunta 1990), which has been 
further classified according to the primarily affected cell type, either the PCs or granule 
cells (granuloprival degeneration) (Urkasemsin & Olby 2014). However, loss of granule 
cells, with relative sparing of PCs, is encountered more rarely (Sisó et al. 2006). In 
many breeds, autosomal recessive mode of inheritance has been either suspected 
(Carmichael et al. 1996, van Tongern et al. 2000, Urkasemsin et al. 2010) or confirmed 
(Zeng et al. 2011, Forman et al. 2012, Forman et al. 2013, Agler et al. 2014, Gilliam et 
al. 2014, Forman et al. 2015), while possible dominant conditions have not yet 
emerged. Similar to humans, dogs affected with progressive cerebellar disorders 
develop significant difficulties in controlling their movements. The clinical signs in 
affected dogs include gait impairment, truncal swaying, broad-based stance, intention 
tremors and abnormal eye movements (nystagmus) (Summers et al. 1995). The onset of 
clinical signs can vary from a few weeks (Yasuba et al. 1988, Coates et al. 1996, Coates 
et al. 2002), to months (deLahunta & Averill 1976, Urkasemsin et al. 2010, Forman et 
al. 2015), or several years (Steinberg et al. 1981, Higgins et al. 1998, Steinberg et al. 
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2000). A large majority of the described conditions have an early onset and a fairly 
quick disease progression (Sisó et al. 2006). In recent years, significant progress has 
been made in identifying disease-associated gene variants (Table 5). However, there are 
still many conditions in which the genetic cause remains to be uncovered (Table 6).  
Currently, the causative or associated gene variant has been reported in six 
autosomal recessive canine ataxias, four of which are linked to genes that have been 
implicated in similar human phenotypes (Table 5). In Coton de Tulear dogs, a 
retrotransposon insertion disrupts the metabotropic glutamate receptor 1 (GRM1) gene, 
causing neonatal cerebellar ataxia with synaptic abnormalities, but no apparent 
degenerative changes (Zeng et al. 2011). In humans, GRM1 mutations result in 
infantile-onset autosomal recessive spinocerebellar ataxia (Guergueltcheva et al. 2012). 
Another type of neonatal ataxia, affecting the Beagle breed, is caused by an 8-bp exonic 
deletion in the SPTBN2 gene (Forman et al. 2012). The encoded β-III spectrin protein 
has been reported to function in Golgi-related protein transport (Salcedo-Sicilia et al. 
2013) and glutamatergic neurotransmission (Jackson et al. 2001). Its defects have been 
linked with both autosomal dominant and recessive ataxia in humans (Ikeda et al. 2006, 
Lise et al. 2012). Early-onset spinocerebellar ataxia within the Italian Spinone breed is 
associated with an intronic GAA-repeat expansion in the inositol 1,4,5-trisphosphate 
receptor 1 (ITPR1) gene (Forman et al. 2015). The ITPR1 receptor has been implicated 
to function in autophagy regulation (Criollo et al. 2007, Vicencio et al. 2009) and 
calcium signaling in the ER (Mikoshiba 2007). In humans, ITPR1 mutations cause 
dominant spinocerebellar ataxia (van de Leemput et al. 2007, Huang et al. 2012). The 
Parson Russel Terrier breed is affected with at least two different forms of 
spinocerebellar ataxia, associated with mutations in the KCNJ10 (Gilliam et al. 2014) 
and CAPN1 (Forman et al. 2013) genes, encoding a potassium channel and a calcium 
dependent cysteine protease, respectively. The KCNJ10 mutation is also found in 
affected dogs from other related terrier breeds (Gilliam et al. 2014, Rohdin et al. 2015). 
In humans, defects in the KCNJ10 gene are linked to an autosomal recessive 
neurological syndrome, characterized by ataxia, seizures and hearing loss (Scholl et al. 
2009). Finally, a late-onset cerebellar ataxia in Old English Sheepdogs and Gordon 
Setters was recently associated with a missense change in the autophagy-linked GTPase 
gene, RAB24 (Agler et al. 2014). The role of RAB24 in autophagy is unclear, but it has 
been shown to localize to autophagosomal membranes (Munafo & Colombo 2002). 
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Table 5. Canine inherited ataxias with an identified genetic cause. 
Affected  
????? 
Clinical features  
(age of onset) 
Pathological  
features 
Gene 
Protein  
Human disease 
(OMIM#) 
Beagle 
Neonatal  
cerebellar ataxia  
(3 weeks) 
PC loss, secondary lesions  
in granular cell layer and 
molecular layer, swollen 
dendritic processes  
(Yasuba et al. 1988,  
Forman et al. 2012) 
SPTBN2 
β-III spectrin 
?SCA5 (#600224)  
?Early-onset 
SCAR14 (#615386) 
Coton de  
Tulear 
Neonatal  
cerebellar ataxia  
(2 weeks) 
Synaptic abnormalities in  
the cerebellar cortex  
(Coates et al. 2002) 
GRM1 
Glutamate  
receptor 
?Early-onset 
SCAR13 (#614831) 
Italian  
Spinone 
Spinocerebellar  
ataxia  
(4 months) 
No clear degenerative 
changes, dendritic 
abnormalities in PCs 
(Forman et al. 2015) 
ITPR1 
Inositol 
trisphosphate 
receptor 
?SCA15 (#606658) 
?SCA29 (#117360) 
Old English 
Sheepdog,  
Gordon Setter 
Cerebellar ataxia  
(6 months - 4 years) 
Neuron loss within the PC 
layer, granular cell layer  
and molecular layer  
(Steinberg et al. 1981, 
Steinberg et al. 2000) 
RAB24 
GTPase Not reported 
Parson Russell 
Terrier, Jack 
Russell Terrier,  
Russell Terrier, 
Smooth-Haired 
Fox Terrier,  
Toy Fox Terrier 
Spinocerebellar 
ataxia, seizures, 
myokymia  
(2-12 months) 
Generalized axonopathy, 
axonal swelling and  
myelin loss in  
spinocerebellar tracts  
(Wessmann et al. 2004, 
Bhatti et al. 2011,  
Gilliam et al. 2014) 
KCNJ10 
Potassium  
channel 
?SeSAME and 
EAST syndromes 
(#612780)  
(ataxia, seizures, 
sensorineural 
deafness)  
Parson Russell 
Terrier 
Spinocerebellar  
ataxia  
(6-12 months) 
Presently unclear1 
CAPN1 
Calcium 
dependent 
cysteine 
protease 
Not reported 
1The histopathological changes are unclear, specifically in comparison to KCNJ10-linked 
ataxia in the same breed (Gilliam et al. 2014). Abbreviations: PC = Purkinje cell; SCA = 
Spinocerebellar ataxia, dominant; SCAR = Spinocerebellar ataxia, autosomal recessive 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review of the literature 
 
 
 
 
34 
Table 6. Canine cerebellar ataxias with an unknown molecular basis. 
Affected 
????? 
Clinical 
features 
Age of onset 
(progression) 
Pathological  
features 
Australian 
Kelpie 
Early-onset 
cerebellar ataxia 
5-12 weeks 
(quick to moderate) 
PC and granule cell loss, degeneration of the 
cerebellar white matter 
(Thomas & Robertson 1989) 
Bavarian 
Mountain 
Dog 
Early-onset 
cerebellar ataxia 
Around 3 months 
(slow) Granule cell loss (Flegel et al. 2007) 
Belgian 
Shepherd 
Malinois 
Early-onset 
cerebellar ataxia 
4-7 weeks 
(quick) 
Degeneration of the cerebellar nuclei, 
vacuolization of granular cell layer and white 
matter, vacuoles in medulla, pons and 
midbrain (Kleiter et al. 2011) 
Bernese 
Mountain  
Dog 
Early-onset 
cerebellar ataxia 
4-6 weeks 
(quick) 
PC and granule cell loss, thinning of 
molecular layer, liver degeneration and 
fibrosis (Carmichael et al. 1996) 
Border  
Collie 
Early-onset 
cerebellar ataxia 
6-8 weeks 
(quick) 
PC and granule cell loss  
(Gill & Hewland 1980) 
Border  
Collie 
Early-onset 
cerebellar ataxia 
4 months 
(quick to moderate) 
Granule cell loss, thinning of molecular layer 
(Sandy et al. 2002) 
Brittany 
Spaniel 
Late-onset 
spinocerebellar 
degeneration 
5-10 years 
(slow) 
PC loss, axonal degeneration 
within the spinal cord (Higgins et al. 1998) 
Coton de 
Tulear 
Early-onset 
cerebellar ataxia 
7-8 weeks 
(quick) 
Granule cell loss, thinning of molecular layer 
(Tipold et al. 2000) 
English 
Bulldog 
Early-onset 
cerebellar ataxia 
10-12 weeks 
(slow) 
PC and granule cell loss  
(Gandini et al. 2005) 
Finnish  
Hound 
Early-onset 
cerebellar ataxia 
4-12 weeks 
(quick) 
PC and granule cell loss, thinning of the 
molecular layer (Tonttila & Lindberg 1971) 
Irish  
Setter 
Neonatal 
quadriplegia and 
amblyopia (ataxia, 
tremors, nystagmus) 
Present from birth 
(quick) 
PC and granule cell loss  
(Palmer et al. 1973, Sakai et al. 1994) 
Jack 
Russel 
Terrier 
Neonatal 
spinocerebellar 
ataxia 
2 weeks 
(quick) 
Granule cell loss, PC vacuolization, vacuolar 
degeneration of the cerebellar white matter 
and dorsolateral tracts of the spinal cord 
(Coates et al. 1996) 
Kerry Blue 
Terrier 
Early-onset 
cerebellar ataxia 
9-16 weeks 
(quick) 
PC and granule cell loss, degeneration of the 
olivary nucleus, subtantia nigra and caudate 
nucleus (deLahunta & Averill 1976) 
Labrador 
Retriever 
Early-onset 
cerebellar ataxia 
9-17 weeks 
(quick) 
PC and granule cell loss  
(Perille et al. 1991) 
Portuguese 
Podengo 
Neonatal cerebellar 
ataxia 
2-3 weeks 
(quick) 
PC loss, thinning of granular cell and 
molecular layers, cerebral white matter loss 
and hydrocephalus (van Tongern et al. 2000) 
Rhodesian 
Ridgeback 
Neonatal cerebellar 
ataxia, growth 
retardation and coat 
color dilution 
2 weeks 
(quick) 
PC and granule cell loss, uneven distribution 
of macromelanosomes within hair safts 
(Chieffo et al. 1994) 
Scottish 
Terrier 
Juvenile to adult 
onset cerebellar 
ataxia 
2 months - 6 years, 
median 7 months 
(slow) 
PC loss; degeneration of the granular and 
molecular layers (Urkasemsin et al. 2010) 
Abbreviations: PC = Purkinje cell 
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???? ??????????tudy 
The principal objective of this PhD study was to identify causative mutations in canine 
inherited diseases, focusing on neurodegenerative and skeletal disorders. The studied 
disease phenotypes were present within particular breeds and many similarly affected 
dogs were reported. This was suggestive of underlying genetic causes, and prompted us 
to pursue genetic examinations. As well as identifying causative gene variants, the aim 
was to recognize disease-linked molecular pathways and gain understanding of the 
biology of the studied diseases. 
 
The specific aims were: 
 
i.  To identify the genetic cause of dwarfism in the Norwegian Elkhound and 
Karelian Bear Dog breeds (Study I). 
 
ii.  To reveal the causative mutation behind cerebellar ataxia in the Finnish Hound 
breed (Study II). 
 
iii.  To study the genetic background of a neurodegenerative vacuolar storage disease 
in the Lagotto Romagnolo breed (Study III). 
Materials and methods 
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4 Materials and methods 
4.1 Ethics statement 
All dogs that were used in the clinical, pathological and genetic experiments were 
privately owned pet dogs, enrolled in the studies with their owners’ consent (Study I-
III). The experiments were carried out with authorization from the “Animal Ethics 
Committee at the State Provincial Office of Southern Finland” (Study I-III: permits 
ESLH-2006-08207/Ym-23, ESHL-2009-07827 and ESAVI/6054/04.10.03/2012) and 
with permission from the “Cantonal Committee For Animal Experiments” (Study III: 
permit 23/10, Canton of Bern). Zebrafish experiments were approved by “Stockholm 
North Experimental Animal committee” (Dnr N29-12). 
4.2 Study cohorts 
Blood samples, buccal swabs and tissue samples were collected from canine subjects in 
order to isolate genomic DNA (Study I-III). Sample collection was focused on affected 
dogs, their parents, unaffected siblings, and other close relatives. Samples were stored 
in the canine DNA bank maintained by the research group of Dr. Lohi at the University 
of Helsinki. The DNA repository currently holds over 50,000 samples from more than 
300 different dog breeds, representing a highly valuable resource for genetic research in 
dogs. In addition to the samples obtained from affected dogs and their healthy relatives, 
the DNA bank was utilized to retrieve larger sample cohorts from unaffected dogs that 
had been collected for other ongoing research projects. These cohorts were used to 
corroborate initial findings and to estimate mutation carrier frequencies within the 
examined breeds, and to screen the disease-associated variants in other breeds. The full 
sample cohorts that were used in Studies I-III are listed in Table 1. More detailed 
information about the cohorts can be found in each individual study.  
A large majority of the DNA samples were acquired as ethylenediaminetetraacetic 
acid (EDTA)-blood, a small proportion as buccal swabs, and a few as tissue samples. 
Blood samples were collected at veterinary clinics or by trained research personnel. 
Buccal swabs could be collected at home by dog owners. Tissue samples were 
harvested during post-mortem examinations.  
In Study III, blood samples were received from a variety of different countries, 
whereas samples in Studies I and II were predominantly from Finland. Study III was 
performed in collaboration with the research group of Dr. Tosso Leeb at the University 
of Bern, Switzerland, and some of the samples used in this study were collected in the 
group’s DNA repository at the University of Bern.  
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Table 1. Study cohorts. 
Study 
# 
Affected 
breed 
Studied 
Phenotype 
Affected 
dogs 
Control 
dogs 
Controls from 
other breeds 
Total 
dogs  
I 
Norwegian 
Elkhound Chondrodysplasia 17 197 
192 761 
Karelian Bear 
Dog Chondrodysplasia 4 351 
II Finnish Hound Cerebellar ataxia 14 274 349 637 
III Lagotto Romagnolo 
Neurodegenerative 
storage disease 22 2,330 642 2,994 
????Pedigrees  
Pedigrees were established around the affected dogs by using the GenoPro genealogy 
software (http://www.genopro.com/) (Study I-III). The pedigrees of Finnish dogs were 
obtained from the Finnish Kennel Club’s pedigree database KoiraNet 
(http://jalostus.kennelliitto.fi/). Other utilized pedigree databases included the Swedish 
Kennel Club’s Hunddata (https://hundar.skk.se/hunddata/) and the Lagotto Pedigree 
database (http://lagotto.hu/database.htm). In addition, pedigree information was 
received from individual dog owners and breeders.  
4.4 Clinical and pathological examinations 
Clinical examinations were performed on affected dogs in Studies I-III and 
pathological examinations in Studies II and III. All pathologically examined dogs were 
euthanized on their owners’ request.  
In Study I, radiographs were taken from altogether three dogs, including two dogs 
affected with chondrodysplasia: a 3-year-old Norwegian Elkhound (NE) and 5-month-
old Karelian Bear Dog (KBD). The third examined dog was an unaffected littermate of 
the 5-month-old chondrodysplastic KBD.  
In Study II, detailed neurological examinations, along with general clinical and 
orthopedical examinations, were performed on ten ataxic Finnish Hound (FH) puppies 
and on one healthy littermate. Brain magnetic resonance imaging (MRI) scans and 
cerebrospinal fluid samples were acquired from all examined dogs. The affected 
puppies were euthanized because of progressive clinical signs and underwent a full 
post-mortem examination. The brain of one additional affected dog was also received 
for pathological studies. Formalin-fixed, paraffin-embedded (FFPE) tissue samples 
from the CNS, liver, lungs, spleen, kidney and heart were stained with haematoxylin-
eosin (HE) and examined under a light microscope. CNS sections were stained with 
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luxol fast blue-cresyl echt violet (LFB-CEV) to examine chromatolysis and myelin loss. 
Immunohistochemistry (IHC) was utilized to detect possible infections by using 
antibodies raised against the canine distemper virus (MCA1893, Serotec; Bio-Rad 
Laboratories Inc., Hercules, CA, USA) and canine parvovirus (MCA2064, Serotec; Bio-
Rad Laboratories Inc., Hercules, CA, USA). Astrogliosis was assessed via a glial 
fibrillary acidic protein (GFAP) antibody (MCA1909, Serotec; Bio-Rad Laboratories 
Inc., Hercules, CA, USA). 
In Study III, general clinical and neurological examinations were performed on 16 
Lagotto Romagnolo (LR) dogs affected with a neurodegenerative disease. Brain MRI 
scans were obtained from 11 affected LRs. A pathological examination was performed 
on seven affected LRs that were euthanized due to worsening clinical signs. FFPE tissue 
samples, collected from internal organs, skin, and the central and peripheral nervous 
system, were stained with HE and periodic-acid-Schiff´s (PAS) stains. Cerebellar 
cortical tissue samples from one affected LR were processed for electron microscopy 
(EM). The EM samples were fixed in 2.5% glutaraldehyde, embedded in epoxy resin 
and stained with the Reynolds lead citrate stain. IHC was used to get insights into the 
disease-causing pathological mechanisms. For this purpose, FFPE tissue samples from 
affected and control dogs were stained using primary antibodies against ubiquitin 
(ab7780, Abcam, Cambridge, UK), the astrogliosis marker GFAP (MCA1909, Serotec, 
Bio-Rad Laboratories Inc., Hercules, CA, USA), the authophagy markers LC3B 
(ab48394, Abcam, Cambridge, UK) and p62/SQSTM1 (P0067, Sigma-Aldrich, St. 
Louis, MO, USA), the lysosome membrane protein LAMP2 (LS-B3144, Lifespan 
Biosciences Inc., Seattle, WA, USA) and the disease-associated ATG4D protein 
(SAB1301447, Sigma-Aldrich, St. Louis, MO, USA). 
4.5 Tissue samples 
Whenever possible, fresh tissue samples were harvested from euthanized animals during 
pathological examination to be utilized in possible functional experiments. The tissue 
samples were stabilized in RNAlater reagent (Ambion, Life Technologies, Carlsbad, 
CA, USA) according to the manufacturer’s instructions and stored in -80 °C until 
further use.  
In Study I, a 3-year-old chondrodysplastic NE was euthanized at its owner’s 
request, due to aggressive behavior towards people and other dogs. A panel of tissue 
samples was collected from this dog after euthanasia. Control tissue samples were 
obtained from a 2-year-old Australian Kelpie that was euthanized due to epileptic 
seizures.  
In Study II, tissue samples were collected from five affected FH puppies’ cerebellar 
cortex. The puppies were euthanized at around 3 months of age. Control samples were 
obtained from an 11-day-old Saluki puppy that had suffered from a peritoneo-
pericardial hernia.  
In Study III, tissues were collected from two 2-year-old affected LRs, and from 
four control LRs. The control dogs comprised an 11-month-old dog that suffered from 
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seizures, a 10-year-old dog with progressive cognitive decline, and a 9-year-old and a 
10-year-old LR that were both euthanized due to severe hip dysplasia. 
4.6 Reference sequences and databases 
The CanFam2.0 dog genome build was used as the reference genome in Studies I and 
II, whereas the CanFam3.1 assembly was used in Study III. The NCBI GenBank 
database (http://www.ncbi.nlm.nih.gov/) was used to retrieve mRNA and protein 
sequences for the studied genes. The Ensembl database was used in Study III to obtain 
zebrafish reference sequences (http://www.ensembl.org/index.html). In Study II, the 
UCSC Genome Browser (http://genome-euro.ucsc.edu) was utilized to identify 
microsatellite markers near ataxia candidate genes. 
4.7 Molecular biology methods 
Several different molecular biology methods were employed. SNP arrays (Study I-III) 
and whole-genome sequencing (Study III) were used to obtain genome-wide genotype 
data. Sanger sequencing was used to screen for possible causative mutations in 
candidate genes (Study I, II), to genotype candidate variants in bigger sample numbers 
(Study I-III), and to verify mRNA sequences (Study I-III). In Study II, fragment 
analysis was utilized to determine allele sizes for microsatellite markers adjacent to 
known human and murine ataxia genes. Taqman genotyping chemistry was used to 
screen the disease-associated variants in large sample cohorts (Study I-III). Gene 
expression differences between affected and healthy dogs were examined by semi-
quantitative PCR and/or real-time quantitative PCR (qPCR) (Study I-III). In Study I, 
immunoblotting was utilized to examine the protein level effects of the identified gene 
mutation.  
4.7.1 DNA, RNA and protein extraction 
Genomic DNA was isolated from most blood samples by using a semi-automated 
Chemagen extraction robot (PerkinElmer Chemagen Technologie GmbH, Baesweiler, 
Germany), which was also used to extract DNA from tissue samples. In Study II, the 
Puregene DNA Purification Kit (Gentra, Qiagen, Hilden, Germany) was used for a 
subset of samples, and in Study III, a part of the sample cohort was extracted by using 
the Nucleon Bacc2 kit (GE Healthcare, Little Chalfont, UK). DNA was extracted from 
buccal swabs by using the QiaAmp DNA Mini Kit (Qiagen, Hilden, Germany).  
Total RNA was extracted from RNAlater preserved tissue samples by using the 
RNeasy Mini Kit (Qiagen, Hilden, Germany). The samples were homogenized with a 
TissueRuptor rotor-stator (Qiagen, Hilden, Germany), and a DNase I digestion step was 
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included in the protocol (RNase-Free DNase Set; Qiagen, Hilden, Germany). In Study 
I, RNA was extracted from tracheal and bronchial tissue samples of one affected and 
one control dog. In Studies II and III, RNA was isolated from cerebellar cortical 
samples of five affected and one unaffected dog, and from two affected and four 
unaffected dogs, respectively. 
The concentration of both DNA and RNA samples was determined by using a 
NanoDrop-1000 UV/Vis Spectrophotometer (Thermo Fisher Scientific Inc., Waltham, 
MA, USA). The DNA samples were stored at -20 °C and the RNA samples at -80 °C 
until further use.  
In Study I, total protein lysates were extracted from RNAlater preserved tracheal 
tissue samples of one affected and one control dog. The samples were homogenized in 
Pierce T-PER Tissue Protein Extraction Reagent (Thermo Fisher Scientific Inc., 
Waltham, MA, USA) by using a TissueRuptor rotor-stator (Qiagen, Hilden, Germany). 
Pierce Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific Inc., Waltham, MA, 
USA) was added to the extraction buffer. Protein concentrations were measured by 
using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific Inc., Waltham, MA, 
USA) and the lysates were stored at -80 °C. 
4.7.2 Primer design 
The Primer3 program (http://frodo.wi.mit.edu/primer3/) was used to design primers for 
fragment analysis, Sanger sequencing and quantitative PCR (Study I-III). Primers used 
in mRNA experiments were designed to span multiple exons in order to control for 
possible contamination with genomic DNA. The used primer sequences are listed in the 
supplementary materials of each individual study. 
?????????, Sanger sequencing and fragment analysis 
Most PCR reactions were performed using Biotools’ DNA Polymerase (Biotools B&M 
Labs S.A., Madrid, Spain) under standard thermocycling conditions. In Study III, the 
AmpliTaq Gold 360 Mastermix (Applied Biosystems, Life Technologies, Carlsbad, CA, 
USA) and the Phusion Hot Start II High-Fidelity DNA polymerase (Thermo Fisher 
Scientific Inc., Waltham, MA, USA) were used in a subset of PCR reactions. A PTC-
225 Peltier Thermal Tetrad Cycler or a T100 Thermal Cycler (Bio-Rad Laboratories 
Inc., Hercules, CA, USA) was used to carry out the reactions. PCR products were run 
on a 1% agarose gel stained with either 0.5 µg/ml ethidium bromide (Amresco Inc., 
Solon, OH, USA) or GelRed (Biotium, Inc., Hayward, CA, USA).  
PCR products were purified for Sanger sequencing by using the ExoSAP-IT enzyme 
mix (GE Healthcare, Little Chalfont, UK) or a combination of Exonuclease I and 
FastAP Thermosensitive alkaline phosphatase (Thermo Fisher Scientific Inc., Waltham, 
MA, USA). Sequencing reactions were carried out on a 3730xl DNA Analyzer (Applied 
Biosystems, Life Technologies, Carlsbad, CA, USA), and the obtained sequence data 
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was analyzed using either Variant Reporter v1.0 (Applied Biosystems, Life 
Technologies, Carlsbad, CA, USA) or Sequencher 5.1 (GeneCodes Corp., Ann Arbor, 
MI, USA). 
In Study II, AmpliTaq Gold Polymerase (Applied Biosystems, Life Technologies, 
Carlsbad, CA, USA) was used to amplify the microsatellite markers for fragment 
analysis. The PCR reactions were carried out either with fluorescence-labeled forward 
primers (HEX or FAM label) or with a FAM-labeled third primer. The intensity of PCR 
products was evaluated from agarose gel, and the products were diluted for the fragment 
analysis runs, which were performed on a 3730xl DNA Analyzer (Applied Biosystems, 
Life Technologies, Carlsbad, CA, USA). Applied Biosystems’ GeneScan-500 LIZ was 
used as a size standard, and the fragment sizes were determined using the Peak Scanner 
software (Applied Biosystems, Life Technologies, Carlsbad, CA, USA). 
4.7.4 Taqman genotyping 
In Studies I-III, custom Taqman SNP Genotyping Assays were used to discriminate 
between different alleles via fluorescent-labeled probes (Applied Biosystems, Life 
Technologies, Carlsbad, CA, USA). The primer and probe sequences were custom-
designed for each genotyping assay, and the sequences can be found in the individual 
studies. The genotyping reactions were run in 96-well format, using Taqman 
Genotyping Master Mix and 7500 Fast Real-Time PCR instrumentation (Applied 
Biosystems, Life Technologies, Carlsbad, CA, USA). Control samples with known 
genotypes were included in each run to facilitate genotype calling. 
4.7.5 Semi-quantitative and real-time quantitative PCR 
In Studies I-III, total RNA isolated from tissue samples was reverse-transcribed to 
cDNA using the High Capacity RNA-to-cDNA Kit (Applied Biosystems, Life 
Technologies, Carlsbad, CA, USA). In each experiment, equal amounts of RNA 
template were added to the reverse transcription reactions. The reverse transcriptase 
PCRs (RT-PCR) were performed on cDNA samples using three different cycle numbers 
(27, 32 and 37), to ensure the detection of logarithmic amplification phases. The RT-
PCR products were run on 1.5% agarose gel to evaluate possible expression differences. 
The qPCR reactions in Studies I and II were run on a 7500 Fast Real-Time PCR 
instrument (Applied Biosystems, Life Technologies, Carlsbad, CA, USA). The 
reactions were carried out in triplicates, using FastStart Universal SYBR Green Master 
(Hoffmann La Roche, Basel, Switzerland). The obtained expression data was 
normalized against two housekeeping controls, GAPDH and YWHAZ. Reaction 
efficiencies were calculated from multi-point dilution series and the comparative ΔΔCt-
method was used to determine relative expression levels (Livak & Schmittgen 2001). 
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4.7.6 Immunoblotting 
In Study I, total protein lysates from tracheal tissue samples of an affected and healthy 
dog were immunoblotted against a polyclonal anti-ITGA10 antibody (SAB1411763, 
Sigma-Aldrich, St. Louis, MO, USA). An anti-GAPDH antibody (39-8600, Invitrogen, 
Life Technologies, Carlsbad, CA, USA) was used as a loading control. Equal amounts 
of protein lysates were run on a 9% SDS-PAGE gel and the separated proteins were 
blotted on a nitrocellulose membrane (Bio-Rad Laboratories Inc., Hercules, CA, USA), 
using a standard western blotting protocol. A horseradish peroxidase-conjugated anti-
mouse IgG antibody (NA931, GE Healthcare, Little Chalfont, UK) and Pierce 
SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific 
Inc., Waltham, MA, USA) were used to detect the antibody signals. 
4.8 SNP arrays and genotyping cohorts 
SNP chip genotyping arrays were utilized to identify disease associated chromosomal 
loci. CanineSNP20 BeadChip of 22,362 validated SNPs (Illumina, San Diego, CA, 
USA) was used as the genotyping platform in Studies I and II, whereas in Study III, 
the genotyping was carried out on the newer CanineHD BeadChip of 173,662 SNPs 
(Illumina, San Diego, CA, USA). In Studies I and II, genotyping was performed at the 
Institute for Molecular Medicine Finland (FIMM) Technology Center (Helsinki, 
Finland), and in Study III, at the GeneSeek laboratory (Neogen Corporation, Lincoln, 
NE, USA). 
In Study I, nine chondrodysplastic and nine normal-height NEs were genotypes 
with the 22K SNP chips. The affected dogs were from different litters and the control 
dogs were case-matched relatives, either second-degree or more distant. 
In Study II, altogether 13 affected FHs and 18 control FHs were genotyped for 
genome-wide analyses using the 22K arrays. The affected dogs came from seven 
different litters. The control samples comprised 11 parents of affected dogs and seven 
healthy littermates. 
In Study III, three affected and four healthy LRs were genotyped with the 173K 
SNP arrays. The genotyping cohort included one separate affected dog from 
Switzerland and 6 dogs from a Finnish nuclear family, two affected and two healthy 
offspring and both parents. 
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4.9 Analysis of SNP chip data 
4.9.1 Quality control 
The quality of the SNP array data was assessed using the PLINK software (Study I-III)  
(Purcell et al. 2007). As a basic quality control measure, the sample gender was 
evaluated from X-chromosomal markers. In family data, the inheritance pattern of 
marker alleles was checked and SNPs with Mendel errors were removed. To remove 
SNPs that showed significant deviation from the Hardy-Weinberg equilibrium, a 
threshold of p ≤ 0.0001 was applied. A > 95% call rate was utilized for both SNPs and 
samples to exclude markers and individuals with low genotyping efficiency. Finally, 
markers with a < 5% minor allele frequency were removed from analyses. 
4.9.2 Association analysis ????????????????? ?????? 
 
In Studies I and III, the PLINK software package (Purcell et al. 2007) was used to 
perform allelic association tests. In Study I, SNP genotypes from nine affected and nine 
healthy NEs were used to perform the Fisher’s exact test, and the genome-wide 
significance of the results was ascertained through phenotype permutation testing (n = 
50,000). In Study II, a basic case-control association test was performed using 13 
affected FHs and seven unaffected siblings. Genome-wide significance was ascertained 
through 100,000 phenotype permutations. In Study III, the PLINK software (Purcell et 
al. 2007) was used to carry out homozygosity mapping in three affected LRs. This 
approach was employed to identify regions of extended homozygosity that were shared 
by the affected dogs.  
??????Family-based analyses 
In Study II, family-based tests were performed on 13 affected and 18 unaffected FHs. 
The analyses were performed only on canine chromosome 8 (CFA8), which had shown 
a significant association signal. The family-based testing, which included parametric 
single-point linkage, association (LD|Linkage) and a joint test of association and linkage 
(LD + Linkage), was carried out under a recessive inheritance model using the 
Pseudomarker program (Hiekkalinna et al. 2011). In Study III, the Merlin software 
(Abecasis et al. 2002) was used to perform parametric linkage analysis on one nuclear 
LR family comprising two parent dogs, two affected and two healthy siblings. The 
linkage analysis was performed under a recessive inheritance model. 
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4.10 Next-generation sequencing 
In Study III, the whole genome of one affected LR was sequenced using next-
generation high-throughput sequencing technology. The sequencing was performed on 
Illumina’s HiSeq2500 instrumentation, which yielded roughly 15.5x coverage of the 
genome. The obtained paired-end reads were mapped to the CanFam3.1 reference 
genome using Burrows-Wheeler Aligner (BWA) (Li & Durbin 2009). The mapped 
reads were sorted and the PCR duplicates labeled using the Picard tools 
(http://sourceforge.net/projects/picard/). The Genome Analysis Tool Kit (GATK) 
(McKenna et al. 2010) was used to call sequence variants. The protein level effects of 
the variants were annotated using the snpEFF software (Cingolani et al. 2012). 
Genomes of 118 dogs from various different breeds sequenced for other projects were 
used as controls to identify homozygous variants unique to the affected LR.  
4.11 Statistical tests 
Statistical tests were performed using the PASW Statistics 18 software (IBM, IBM, 
Armonk, NY, USA). In Study I, several body-length measurements were acquired from 
nine chondrodysplastic and 25 unaffected NEs. Statistical testing was used to determine 
whether the measurements were significantly different between the affected and 
unaffected animals. The Levene’s test was used to evaluate the equality of variances (p 
> 0.05), and if fulfilled, the Student’s t-test was used, otherwise the Mann-Whitney U-
test was applied. In Study II, the statistical significance of qPCR results determined 
using the Student’s t-test on normalized mean cycle threshold (Ct) -values.  
??????????????????????????????????? 
In Study II, the Pfam database (http://pfam.sanger.ac.uk/) (Finn et al. 2010) and the 
SMART tool (http://smart.embl-heidelberg.de/) (Schultz et al. 1998, Letunic et al. 
2009) were used to examine protein domain structure. In Studies II-III, multiple-
species protein alignments were constructed to evaluate the evolutionary conservation 
of the disease-linked amino acid positions. The ClustalW2 (Study II) 
(http://www.ebi.ac.uk/Tools/clustalw2/) and the Clustal Omega (Study III) 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) sequence alignment algorithms were used 
for this purpose. Pathogenicity prediction tools were used to evaluate the impact of the 
identified missense variants. In Study II, three different programs were used: 
PANTHER (http://www.pantherdb.org/tools/) (Thomas et al. 2003), PolyPhen-2 
(http://genetics.bwh.harvard.edu/pph2/) (Adzhubei et al. 2010) and SIFT (http://sift. 
jcvi.org/) (Ng & Henikoff 2001, Kumar et al. 2009). In Study III, the PredictSNP 1.0 
program was utilized to obtain a consensus pathogenicity estimate from several 
prediction programs (http://loschmidt.chemi.muni.cz/predictsnp/) (Bendl et al. 2014). 
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?????Zebrafish experiments 
In Study III, a zebrafish (Danio rerio) knock-down model was utilized to study the 
developmental role of the disease-associated ATG4D gene. The knock-down of the 
zebrafish orthologue atg4da (ENSDART00000152289) was carried out via an atg4da 
splice-morpholino (atg4daSMO) (Gene Tools, LLC, Philomath, OR, USA). The splice-
morpholino oligo was designed to bind to intron 1 and exon 2 of the atg4da pre-mRNA, 
thus disturbing normal splicing. The used morpholino sequences are listed in S7 Table 
of Study III. To obtain morphant zebrafish, 1-cell stage embryos from a wild-type AB 
strain were injected with ~2-3 ng of the atg4daSMO or a control morpholino. The 
splicing effect and specificity of the atg4daSMO was evaluated by RT-PCR. The RT-
PCR products were run on a 3% agarose gel and extracted from the gel for Sanger 
sequencing by using the GenElute Gel Extraction Kit (Sigma-Aldrich, St. Louis, MO, 
USA). The phenotypes of the morphant and control embryos were examined by 
performing whole-mount immunostaining as described previously (Bae et al. 2009). 
The integrity of the developing cerebellum was assessed by using antibodies raised 
against the PC marker proteins Pvalb7 (1:1000; mouse ascites) and zebrin II (1:200; 
hybridoma supernatant), and the granule cell marker Vglut1 (1:1000; purified antibody). 
Immunostaining signals were detected via an anti-mouse Alexa 488 secondary antibody 
(Molecular Probes, Life Technologies, Carlsbad, CA, USA) and a spinning disk 
confocal microscope (Andor Technology Ltd., Belfast, UK). 
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5 Results and discussion 
5.1 A nonsense mutation in the integrin gene ITGA10 causes 
canine chondrodysplasia (Study I) 
5.1.1 Disproportionate dwarfism of varying severity in two dog breeds 
In 2009, we set out to identify the genetic cause of disproportionate short-stature 
dwarfism that was affecting the Finnish NE population. A corresponding condition had 
been described in a litter of inbred NEs from the United States already in the 1980s 
(Bingel & Sande 1982). Similar to the present-day dwarf dogs, the previously examined 
affected animals had been short-stature dwarfs, with disproportionately short and curved 
limbs. Pathological examinations had revealed several growth plates abnormalities, such 
as disorganized chondrocyte columns and unusual chondrocyte morphology (Bingel & 
Sande 1982).  
During the course of our genetic study, a similar type of chondrodysplasia was 
recognized in the KBD breed, which is another Nordic hunting breed. Both the NE and 
KBD represent “primitive-type” dog breeds with long limbs, the affected dogs having 
considerably shorter limbs in comparison (Fig. 1). We obtained three different body 
length measurements from nine adult chondrodysplastic NEs (nmales = 6; nfemales = 3) and 
from 25 unaffected adult NEs (nmales = 14; nfemales = 11). Statistical analyses revealed 
significant differences in forearm length and in height at withers between cases and 
controls in both sexes (I/Fig. 2, Table 1). 
Radiographic examination of a 3-year-old dwarf NE and a 5-month-old dwarf KBD 
revealed skeletal changes that varied in severity. The radiographs of the adult NE 
showed only relatively mild abnormalities such as slightly bowed radii, whereas more 
distinct changes were present in the KBD (I/Fig. 4). When compared to its unaffected 
sibling, the 5-month-old KBD had significantly shorter and curved radii and ulnae, 
malformed femoral heads, subluxated hip joints, irregular length of carpal and 
phalangeal bones, irregular and flared growth plates and widened vertebral epiphyses. 
The radiographic findings were in line with the general clinical status of the dogs. The 
adult NE did not suffer from noticeable movement difficulties, unlike the 5-month-old 
KBD, which presented with outward pending wrists (carpal valgus), knock knees (genu 
valgus) and preferred not to stand up because of the hip dysplasia (I/Fig. 1). However, 
the majority of dwarf dogs in our study were not as severely affected. Overall, the 
radiographic findings in our study were in accordance with the initial disease 
characterization from 1982 (Bingel & Sande 1982).  
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Figure 1. Affected and healthy dogs. A) An unaffected adult Norwegian Elkhound (NE) 
(Photograph by Arto Rantanen). B) A chondrodysplastic adult NE (Photograph by 
Saija Nieminen) C) A normal-height 5-month-old male Karelian Bear Dog and D) 
its affected male sibling. 
5.1.2 Chondrodysplasia locus maps to canine chromosome 17 
A pedigree that was established around the affected Finnish NEs was consistent with an 
autosomal recessive mode of inheritance (I/Fig. 3A). To identify the genetic cause of 
the condition, nine affected and nine healthy NEs were selected for a genome-wide 
association study. The 18 samples were genotyped using Illumina’s canine 22K SNP 
arrays, resulting in 14,626 informative SNPs. The Fisher’s exact test revealed a 
genome-wide significant association on CFA17 (praw = 7.42x10-6; pgenome-wide = 0.013). 
Within the associated region, all nine cases shared a 2-Mb homozygous haplotype block 
that spanned from 60 to 62 Mb (CanFam2.0 assembly) and contained altogether 33 
genes (I/Fig. 5). A careful inspection of the 33 genes uncovered a highly promising 
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candidate gene, the integrin alpha 10 (ITGA10). The ITGA10 gene was found to encode 
the α10-integrin protein, which is a subunit of the heterodimeric α10β1 integrin receptor 
that binds collagens and is expressed in growth plate chondrocytes (Camper et al. 1998, 
Tulla et al. 2001, Camper et al. 2001). Moreover, Itga10 knockout mice had been 
reported to present with a mild chondrodysplastic phenotype (Bengtsson et al. 2005). 
5.1?? A nonsense mutation in ITGA10 causes loss of α10 integrin 
The protein coding regions and exon-intron junctions of the ITGA10 gene were 
sequenced in two affected and two healthy NEs, revealing altogether four intronic and 
five exonic variants (I/Table 2). However, only one of the variants segregated with the 
phenotype, when the other eight were homozygous in all four dogs. This variant was a 
single nucleotide change c.2083C>T in exon 16, predicted to introduce a premature stop 
codon p.Arg695* to the encoded protein. The c.2083C>T change was genotyped in 
larger sample cohorts, including the KBDs and a NE family cohort from the United 
States. The genotyping revealed a complete segregation of the nonsense variant with the 
chondrodysplasia phenotype (Table 2). Samples were obtained from altogether 21 
affected dogs, all of which were homozygous for the c.2083C>T change. As further 
proof of pathogenicity, the variant was absent in 192 dogs from 12 other breeds 
(I/Table S1). Mutation carrier frequencies were calculated from separate population 
cohorts, indicating a 24% and an 8% frequency within the NE and KBD breeds, 
respectively (Table 2).  
 
Table 2. ITGA10 c.2083C>T genotypes in the studied sample cohorts. 
?????? 
country 
Cohort/ 
status 
Number 
of dogs 
Wild-type 
(C/C) 
?????????????
(C/T) 
???????????
(T/T) 
Norwegian 
Elkhounds, 
Finland 
Unaffected relatives 32 15 (47%) 17 (53%) - 
Affected dogs 13 - - 13 (100%) 
Population cohort 156 119 (76%) 37 (24%) - 
Norwegian 
Elkhounds, USA 
Unaffected relatives 9 2 (22%) 7 (78%) - 
Affected dogs 4 - - 4 (100%) 
Karelian Bear 
Dogs, Finland 
Unaffected relatives 64 44 (69%) 20 (31%) - 
Affected dogs 4 - - 4 (100%) 
Population cohort 287 263 (92%) 24 (8%) - 
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The ITGA10 gene is composed of altogether 30 exons. The p.Arg695* nonsense 
mutation in exon 16 introduces a premature stop-codon that eliminates nearly half of the 
protein body (I/Fig. 6). As a consequence of the premature stop-codon, the mutated 
ITGA10 transcript was expected to undergo nonsense-mediated mRNA decay (NMD) 
(Nagy & Maquat 1998). However, our RT-PCR and qPCR analyses, carried out with 
tissue samples from one affected and one control dog, did not provide evidence of NMD 
(I/Fig. 7A, Fig. S1). To examine this further, we evaluated the α10-protein levels in 
cartilaginous tracheal tissue lysates using a polyclonal ITGA10 antibody. The 
immunoblotting experiments revealed a strong band of the expected ~150 kDa size in 
the control lysate, whereas the sample from an affected dog showed no signal (I/Fig. 
7B), indicating that either the entire α10-subunit is lost due to the mutation, or the used 
antibody does not recognize a possible truncated polypeptide. Either way, the identified 
nonsense mutation most likely results in loss of protein function. 
5.1.4 Collagen-binding α10β1-integrin is needed for bone growth 
In summary, this study identified a nonsense mutation in the ITGA10 gene as the cause 
of chondrodysplasia in the NE and KBD breeds. The affected dogs suffer from short-
stature dwarfism that varies in severity. Our immunoblotting results indicate that the 
canine phenotype is caused by loss of protein function, as the full-length α10-protein 
was not detected in the affected tissue.  
The integrin α10-subunit, encoded by the ITGA10 gene, assembles into the α10β1 
receptor, a collagen-binding integrin predominantly found in cartilage chondrocytes 
(Camper et al. 2001). Altogether four collagen-binding integrins, α1β1, α2β1, α10β1 
and α11β1 have been recognized in vertebrates (Fig. 2A) (Leitinger 2011, Heino 2014). 
Neither the ITGA10 gene nor the other collagen-binding integrins have been previously 
implicated in monogenic diseases. Collectively, the integrin family of transmembrane 
cell surface receptors constitutes 24 distinct αβ-heterodimers that mediate ECM and 
cell-cell interactions in a variety of different tissues and pathways (Fig. 2B) (Barczyk et 
al. 2010, De Franceschi et al. 2015). The α10β1 integrin has been indicated to influence 
chondrocyte proliferation and the assembly of collagen fibrils in the surrounding ECM 
(Bengtsson et al. 2005). The nonsense mutation in affected dogs is likely to severely 
disrupt these functions. The α10β1 integrin is only the second collagen receptor that has 
been linked with inherited chondrodysplasia. Mutations in the discoidin domain 
receptor 2 (DDR2) have been reported to cause short-limbed dwarfism both in mice 
(Labrador et al. 2001, Kano et al. 2008) and in humans (Bargal et al. 2009). Similar to 
α10β1, the DDR2 receptor serves as a collagen-binding cell surface receptor, which is 
thought to be involved in regulating chondrocyte proliferation (Labrador et al. 2001, 
Kawai et al. 2012).  
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Figure 2. Integrin structure and signaling. A) A schematic presentation of the structure of 
the four collagen-binding integrins, α1β1, α2β1, α10β1 and α11β1. The collagen-
binding integrins constitute a subgroup of integrin receptors that share the β1-
subunit and possess an I-domain within the α-subunit. The yellow star denotes the 
approximate position of the identified nonsense change in the canine α10-subunit. 
B) The basic modes of integrin signaling. Binding of extracellular ligands gives 
rise to conformational changes, and may result in clustering of integrin 
heterodimers. Ligand binding can have an effect on various intracellular 
processes, such as cell proliferation and gene expression. The integrin receptors 
can also be activated through intracellular proteins, such as Talin-1, which 
increase affinity for extracellular ligands. However, although conceptually 
separate, the two signaling modes are dynamic and interlinked. The figure is 
adapted from Askari et al. 2009, Shattil et al. 2010, and Leitinger 2011. 
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The canine chondrodysplasia phenotype suggests a critical role for the α10β1 receptor 
in endochondral ossification. The biological importance of the four collagen-binding 
integrins has been explored in mouse-models. Inactivation of all β1 integrins in murine 
chondrocytes causes perinatal lethality and severe chondrodysplasia (Aszodi et al. 
2003), but only a relatively mild phenotypes result from the knockdown of the 
individual α10-subunits of the collagen-binding integrins (Gardner et al. 1996, Chen et 
al. 2002, Holtkotter et al. 2002, Zemmyo et al. 2003, Bengtsson et al. 2005, Popova et 
al. 2007). Deficiency of the murine α10 causes a subtle reduction in the length of long 
bones (Bengtsson et al. 2005), whereas the affected dogs present with marked skeletal 
changes. It is plausible that the loss of α10 function in humans would resemble the 
canine phenotype, rather than the murine one. Then again, other types of mutations in 
the ITGA10 gene could result in milder or otherwise different skeletal phenotypes in 
humans, as well as in dogs. In addition to the α10β1 receptor, cartilage chondrocytes 
also express other integrins (Salter et al. 1995), and although these have not been 
associated with inherited chondrodysplasias, they may be involved in the pathogenesis 
of other cartilage-related diseases, such as osteoarthritis (Zemmyo et al. 2003, Loeser 
2014, Tian et al. 2015). 
The full segregation of the ITGA10 mutation with the chondrodysplasia phenotype 
in two different dog breeds is a strong indicator of its causative nature. It is likely that 
the mutation is identical by descent in the two breeds. The chondrodysplasia phenotype 
was described already a few decades ago in the American NE population (Bingel & 
Sande 1982), and our results confirm the presence of the mutation in a present-day 
family cohort from the United States. However, we did not have the samples to estimate 
the overall carrier frequency in the American NE population. The current high carrier 
frequency of the mutation in the Finnish NEs is probably due to chance and breeding 
practices. The mutation was less frequent in the Finnish KBD population, and may have 
been introduced to KBDs through crossbreeding with NEs in the recent past. Pedigree 
analysis in the KBDs suggested that a single popular sire from the 1980’s highly 
increased the frequency of the mutated allele in KBDs (I/Fig. 3C). In our KBD sample 
cohort, all except one heterozygous animal were descendants of this particular popular 
sire, which was suspected of having been part NE.  
As a result of this study, a gene test is now available to help recognize mutation 
carriers, which is particularly important for the NE breed, in light of the high carrier 
frequency within the breed. As a whole, this study shows that larger-sized animals, such 
as the dog, may be more suitable to model human skeletal disorders than small 
mammals. Our findings establish the ITGA10 gene as a highly plausible candidate gene 
in human chondrodysplasias. 
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5.2 A missense change in the SEL1L gene implicates defective 
protein degradation in canine cerebellar ataxia (Study II) 
5.2.1 Early-onset cerebellar degeneration in Finnish Hound dogs 
In 2006, our research group initiated a genetic study to identify the molecular genetic 
cause of cerebellar ataxia in FH dogs. In 1971, a case study in the Finnish Veterinary 
Journal had described a FH puppy affected with cerebellar ataxia (Tonttila & Lindberg 
1971). The puppy had presented with progressive ataxia, starting around the age of three 
months. The condition progressed quickly to a point at which eating became 
increasingly difficult due to uncontrolled head movements. The affected dog was 
euthanized at the age of 5 months, and post-mortem examination revealed marked 
cerebellar cortical atrophy. The authors proposed an underlying genetic cause, as 
another puppy from the same litter had presented with corresponding neurological 
problems. Furthermore, subsequent inquiries revealed that puppies with similar clinical 
signs had been previously encountered in at least eight different FH litters (Tonttila & 
Lindberg 1971).  
During 2006-2008, detailed clinical examinations were performed on ten ataxic FH 
puppies (Fig. 3) and on one unaffected littermate. The examinations took place when 
the puppies were from 3 to 4 months old. The owners of the affected dogs had noticed 
the first clinical signs at the mean age of 9 weeks, ranging from 4 to 12 weeks (II/Table 
1). General clinical and orthopedical examination did not uncover abnormalities. Serum 
biochemistry profiles, complete blood cell count and cerebrospinal fluid cell count were 
within normal limits. However, neurological examination revealed generalized 
cerebellar ataxia, intention tremors and deficits in postural reactions in all examined 
affected dogs (II/ Videos S1-S3). MRI of the brain indicated reduced size of the 
cerebellum in nine out of ten affected dogs (II/Fig. 1) Due to rapid worsening of the 
clinical signs, all affected puppies were euthanized upon the owners’ agreement and 
underwent post-mortem examination. 
Pathological examinations did not reveal significant changes outside of the nervous 
system. Within the CNS, histological changes were confined to the cerebellum, and 
characterized by marked PC degeneration and subsequent loss of granule cells (II/Fig. 
2). The most profoundly affected cerebellar regions were the vermis and the paramedian 
lobules, whereas some areas, such as the paraflocculi and flocculus, were mostly 
unaffected. As a whole, the findings reported in the 1970’s case study were consistent 
with the clinicopathological findings in our study, implicating that the disease 
phenotype has been present in the breed for several decades. 
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????????? Affected Finnish Hound dogs. A) A 3-month affected male puppy during the 
testing of postural reactions. B) Another 3-month-old affected male puppy. Note 
the abnormal posture in both dogs. 
5.2.2 Ataxia locus maps to canine chromosome 8 
Analysis of FH pedigree data strongly supported our hypothesis of an autosomal 
recessive inheritance mode. All parents of affected dogs were healthy, both sexes were 
equally affected and the proportion of affected dogs within the disease pedigree was 
close to 25% (II/Fig. 3).  
The genetic examinations in FH ataxia were initiated with a candidate gene 
approach. For this purpose, we selected 24 genes that were known to cause ataxia either 
in humans or in mice (II/Table S1). The possible involvement of these genes in FH 
ataxia was studied through segregation of microsatellite markers in three nuclear 
families. However, none of the markers co-segregated with the phenotype in the 
examined families. 
As the next step, we employed the genome-wide approach to shed light onto the 
underlying genetic cause. Illumina’s 22K canine SNP chips were used as a genotyping 
platform for a cohort of 31 dogs, comprising 13 affected dogs, seven healthy siblings 
and 11 obligate carrier parents. A basic case-control test was carried out using the 
unaffected siblings as controls. This revealed a genome-wide significant association on 
CFA8 (praw = 1.1x10-7 and pgenome = 7.5x10-4), which was confirmed by family-based 
analyses in the full cohort (LOD score = 3.3, association p = 2.2x10-7 and joint analysis 
p = 4.0x10-10) (II/ Fig. 4A, B). The CFA8 locus contained a 1.5-Mb homozygous 
haplotype that was shared by all affected dogs, spanning from 56.0 to 57.5 Mb 
(CanFam2.0 assembly) (II/Fig. 4C). Within this haplotype, a single SNP 
(BICF2P948919) co-segregated fully with the phenotype. This SNP was intronic to the 
sel-1 suppressor of lin-12-like (SEL1L) (II/Fig. 4D), which was considered the strongest 
candidate gene within the associated locus due to its function in a protein quality control 
and degradation pathway (Lilley & Ploegh 2005, Mueller et al. 2006, Mueller et al. 
2008). This was thought promising, as problems in protein degradation are found in 
many neurodegenerative diseases. However, six other genes were also present in the 
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haplotype (Table 3). According to the CanFam2.0 genome assembly, two of the genes 
were probable pseudogenes, and these were therefore excluded from detailed analysis. 
The remaining five genes were screened for possible causative mutations by sequencing 
their exons and exon-intron boundaries in two affected dogs and in two obligate disease 
carriers. Out of the five studied genes, only SEL1L contained variants that were within 
the protein coding regions, and only one of these variants was a non-synonymous 
change with a protein level effect (II/Table S2).  
 
???????? Genes within the ataxia locus on canine chromosome 8. 
Gene  
symbol 
Gene  
name 
Chr8  
position (Mb)1 
Gene 
function Screened 
Reference 
(mRNA) 
CEP128 Centrosomal protein 128kDa  55.954-56.346 Unknown Yes XM_547936.3 
TSHR 
Thyroid 
stimulating 
hormone receptor  
56.364-56.520 
Controls 
thyroid cell 
metabolism 
Yes NM_001003285.1 
GTF2A1 
General 
transcription 
factor IIA  
56.562-56.607 Transcription initiation Yes XM_849814.1 
STON2 Stonin 2  56.635-56.739 
Regulation of 
endocytic 
complexes 
Yes XM_547937.3 
SEL1L Sel-1 suppressor  of lin-12-like 56.808-56.861 
ER-
associated 
protein 
degradation 
Yes XM_537530.2 
LOC612107 Uncharacterized hypothetical gene 57.034-57.111 
Possible 
pseudogene2 No XM_863603.3 
LOC100687147 
NIMA-related 
kinase 6 
pseudogene 
57.396-57.397 Pseudogene No XM_846279.1 
1The positions refer to the CanFam2.0 genome assembly. 2The gene was later annotated as a 
non-coding RNA gene in the CanFam3.1 assembly. 
5.2???Affected dogs have a missense mutation in the SEL1L gene 
Mutation screening of the candidate genes revealed a homozygous c.1972T>C single 
nucleotide alteration in exon 19 of the SEL1L gene, predicted to cause a p.Ser658Pro 
amino acid change in the encoded protein (II/Fig. 4E, 5). In our entire FH family 
cohort, the c.1972T>C change showed full segregation with the ataxia phenotype. All 
13 affected dogs were homozygous for the variant and all 13 obligate carrier parents 
were heterozygous. Out of 20 unaffected siblings, 12 were heterozygous for the variant 
and the remaining eight were homozygous for the reference allele. A 10% mutation 
carrier frequency was indicated in a population cohort of 241 unaffected FHs, whereas 
in 349 dogs from 51 other breeds, the variant was completely absent. 
The SEL1L protein localizes to the ER, where it attaches to the ER membranes by 
its carboxy-terminal transmembrane domain. The amino-terminal protein body lies in 
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the ER lumen and is composed of a fibronectin type II domain and three clusters of α/α-
helical Sel1-like repeat motifs, which are a type of tetratricopeptide repeats (Biunno et 
al. 2006) that have been suggested to mediate protein-protein interactions (Blatch & 
Lassle 1999, Mittl & Schneider-Brachert 2007). The SEL1L p.Ser658Pro change was 
positioned on one of the evolutionary conserved Sel1-repeats within the carboxy-
terminus of the protein (II/Fig. 5). The pathogenicity of the amino acid change was 
assessed trough the bioinformatics prediction tools PANTHER, PolyPhen and SIFT, all 
of which estimated it to have a damaging effect. Collectively, the complete segregation 
of the SEL1L c.1972T>C variant with the phenotype, the position of the amino acid 
change in a conserved protein domain, and the pathogenicity prediction results offer 
strong support for causality. 
Since the pathological changes were restricted to the cerebellum, we used RT-PCR 
to confirm that the SEL1L gene is expressed in cerebellar tissue. The entire SEL1L 
transcript was successfully amplified and sequenced from cerebellar cortical tissue 
samples of affected and healthy dogs, verifying the cerebellar gene expression. Apart 
from the c.1972T>C variant, the obtained sequence data did not deviate from the 
reference sequence and there was no indication of differential mRNA splicing. As a 
next step, we wanted to examine whether there are signs of increased ER stress in the 
affected dogs’ cerebellar cortex. The SEL1L protein functions in an ERAD pathway as 
a part of a protein quality control and degradation machinery (Mueller et al. 2008, Iida 
et al. 2011). Its loss has been reported to cause ER stress in murine models (Francisco et 
al. 2010, Sun et al. 2014). We therefore studied the relative expression levels of several 
genes that are a part of the unfolded protein response (UPR), a mechanism that 
promotes cell survival during ER stress by upregulating several ERAD-related genes 
(Hetz 2012). Our qPCR results revealed increased expression levels for the studied UPR 
genes in affected dogs (II/Fig. 6B). An especially high 14-fold increase was found in 
the expression of a proapoptotic transcription factor CHOP, known to be highly 
upregulated during ER stress (Ron & Habener 1992, Okada et al. 2002, Nishitoh 2012). 
Prolonged UPR activity has been linked to cell death in neurodegenerative diseases and 
in other pathological states (Lindholm et al. 2006, Sano & Reed 2013). Our findings 
suggest that the SEL1L mutation in affected dogs causes ER stress and activates the 
UPR pathway. 
5.2.4 SEL1L mutation links an impaired ERAD pathway to cerebellar 
degeneration 
In summary, this study revealed a homozygous missense mutation within a conserved 
functional domain of the SEL1L gene in FH dogs with cerebellar ataxia. The affected 
dogs presented with early-onset, quickly-progressing movement incoordination. The 
cerebellum of affected dogs was atrophied and showed marked PC loss.  
The role of SEL1L in protein quality control within the ER makes it a highly 
plausible candidate gene in a neurodegenerative phenotype. The ER is a cellular 
organelle made up of a network of membranes that serve as a major site of protein 
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synthesis, folding, post-translational modification and transport (Ellgaard & Helenius 
2003). ER stress, UPR activation and accumulation of aberrant proteins have been 
reported in several neurodegenerative phenotypes (Hetz & Mollereau 2014). The ER-
membrane-bound SEL1L has been suggested to function as an adaptor protein within a 
multiprotein ERAD complex that includes the E3 ubiquitin ligase HRD1 (Fig. 4) 
(Mueller et al. 2006, Christianson et al. 2008, Hosokawa et al. 2008, Cormier et al. 
2009, Iida et al. 2011, Sun et al. 2014). Mouse models and cell line experiments have 
implicated a critical role for the SEL1L protein in cellular homeostasis. Its loss results 
in altered ER morphology, ER stress, protein degradation defects, reduced translation 
efficiency, impaired protein secretion and premature cell death (Francisco et al. 2010, 
Sun et al. 2014). Accordingly, our qPCR results were indicative of ER stress within in 
the cerebellar cortex of affected dogs. Prolonged ER-stress and alterations in ER 
homeostasis may therefore be the cause of premature neuron loss in FH dogs. 
Bioinformatic prediction tools estimated that the SEL1L missense change in affected 
dogs is deleterious. However, since Sel1l-deficiency causes embryonic lethality in mice 
(Francisco et al. 2010), it is possible that the canine mutation does not completely 
disrupt protein function. Furthermore, SEL1L isoforms that lack some of the carboxy-
terminal protein regions have been indicated to function in parallel or complementary to 
the full-length protein (Harada et al. 1999, Biunno et al. 2006, Cattaneo et al. 2009, 
Cattaneo et al. 2011). Overall, the partial function of the mutated protein and/or the 
existence of isoforms that do not contain the mutation position could help explain the 
cerebellum- restricted pathology in affected dogs. Moreover, since the cerebellar PCs 
have been suggested to be especially sensitive for disruptions in proteostasis (Hekman 
& Gomez 2015), they may also be more vulnerable to defects in the HRD1-SEL1L 
pathway than other cell types. SEL1L gene expression has been reported in several 
different fetal and adult tissues, with a particularly strong expression levels in the 
pancreas (Biunno et al. 1997, Donoviel et al. 1998, Biunno et al. 2006). Accordingly, 
previous studies have implicated a role for SEL1L in pancreatic function (Li et al. 2010, 
Sun et al. 2014). Unfortunately, the pancreas was not subject to histological 
examination in affected FHs. However, neither did the clinical picture, nor the gross 
pathological examination suggest pancreatic malfunction in affected dogs. In support of 
the neuronal phenotype in FHs, our RNA-level experiments indicate that SEL1L is 
expressed in the cerebellar cortex of affected and healthy animals. This is in accordance 
with publicly available protein expression data obtained from the adult human 
cerebellum, which shows SEL1L signals in the PCs, as well as in the cells of the 
molecular layer (http://www.proteinatlas.org). 
As a whole, the results of this study are in line with previous knowledge on the 
importance of protein quality control and degradation to neuronal survival. However, 
our findings directly link the HRDI-SEL1L complex to inherited cerebellar 
degeneration, which suggests that the pathway is critical for post-natal PC survival and 
cerebellar function. Furthermore, our results implicate SEL1L as a promising new 
candidate gene for human early-onset ataxias. In addition, the findings of this study 
have already helped prevent the birth of affected dogs through genetic testing.  
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Figure 4. A schematic presentation of the mammalian HRD1-SEL1L complex. The HRD1-
SEL1L complex serves as a scaffold for different components of the mammalian 
ER-associated degradation (ERAD) pathway. The initial recognition of terminally 
misfolded proteins is carried out by several ERAD components, such as the 
chaperone proteins BiP and ERdj5, the EDEM family of lectins, and the XTP3-B 
and OS-9 proteins. SEL1L is thought to function as an adaptor protein. It may 
facilitate the delivery of ERAD substrates to the HRD1-ligase complex by binding 
to recognized target proteins. After being recognized and delivered to the ER-
membrane, the misfolded proteins are ubiquitinated by the E3 ligase HRDI, 
translocated to the cytosol, and finally, degraded by the proteasome. The 
transportation of client proteins through the membrane is powered by the VIMP-
anchored ATPase p97, which forms a complex with the Ufd1 and Npl4 proteins. 
The identity of the actual retrotranslocon channel is not currently clear but the 
process may involve the Derlin proteins, HERP and HRD1. The figure is adapted 
from Hoseki et al. 2010, Kadowaki & Nishitoh 2013 and Christianson & Ye 2014. 
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??? The autophagy-related ATG4D gene is associated with a 
canine neurodegenerative disease (Study III) 
???.1 Cerebellar ataxia and ?????????????????????? in a novel canine disease 
The LR is a dog breed that originates from Italy, where it was initially utilized as a 
water retriever (Fig. 5). A previous clinical study described two isolated LR cases that 
presented with a very early-onset cerebellar degeneration (Jokinen et al. 2007). In this 
study, we recognized a novel neurodegenerative disease with distinct pathological 
changes that affects the breed. The presently studied disorder was first encountered in 
2013 when three adult LRs were euthanized due to progressive ataxia. 
During the genetic study, altogether 22 affected LRs were identified. The 
predominant clinical sign in the affected dogs was progressive cerebellar ataxia (III/S1 
Video). A subset of dogs presented with episodes of abnormal eye movements 
(nystagmus), and as the disease progressed, some developed behavioral changes. The 
first clinical signs were noticed in the affected dogs at the mean age of two years, 
ranging from 4 months to 4 years. The rate of disease progression varied from months 
to several years. Detailed neurological examination was performed on 16 affected 
animals. The examined dogs presented with cerebellar ataxia of varying severity, and 
showed abnormal responses when tested for hopping reactions, patellar reflexes and 
menace reaction. Brain MRI was performed on eleven affected dogs, revealing signs of 
cerebellar atrophy in nine examined dogs. 
 
 
Figure 5.  Lagotto Romagnolo dogs. A) An unaffected Lagotto Romagnolo (LR) 
(Photograph by Marko Saren). B) A blood sample is drawn from another 
unaffected LR dog for the genetic study. 
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Pathological examination was performed on seven affected LRs, all euthanized due to 
worsening clinical signs. The most notable histological finding in the affected dogs was 
clear cytoplasmic vacuolization that ranged from fine vesiculation to large vacuoles 
(III/Fig. 1A). The vacuolar change was present in the nervous system, but also in other 
tissues. Within the CNS, the cerebellar cortex was one of the most consistently and 
severely affected tissues (III/Fig. 1B), along with several specific nuclei, such as the 
deep cerebellar nuclei and nucleus vestibularis. Milder changes were seen in other 
regions, including the cerebral cortex. Axonal spheroids were indicative of disturbed 
axonal transport within the cerebellum and brainstem (III/Fig. 1E). Marked PC and 
granule cell loss was seen in the cerebellar cortex (III/Fig. 1C, D), which was likely the 
major cause of clinical signs in affected dogs. In extraneuronal tissues, vacuolization 
was present in tissues of mesodermal origin, such as the smooth muscle cells, and in 
several different secretory epithelial tissues, including the salivary glands, pancreatic 
acinar cells and the parathyroid gland (III/Fig. 1F). The vacuolar change was also 
found within apocrine sweat glands in skin biopsies of three symptomatic dogs. The 
possible content of the vacuoles could not be determined in HE or PAS stainings. EM 
sections of cerebellar PCs revealed single-membrane-bound vacuoles, which appeared 
either empty or contained small amounts of membranous or floccular material (III/Fig. 
1G). Overall, the pathological changes in affected LRs did not directly correspond to 
previously characterized disorders. The vacuolization was indicative of a LSD, but the 
lack of specific, identifiable storage materials, such as lipofuscin or glycogen, did not 
rule out alternate disease etiologies. 
???.2 A missense change in the autophagy-related ATG4D gene 
A genome-wide approach was utilized to get insights into the genetics of the disorder. 
The genetic study was initiated when DNA-samples had been obtained from three 
pathologically confirmed affected dogs, comprising two LR siblings from Finland and 
one distantly related LR from Switzerland. The three affected dogs were genotyped 
using Illumina’s 170K canine SNP chips, along with the unaffected parents and two 
healthy siblings of the Finnish cases (III/ Fig. 2A). In addition, we performed whole-
genome sequencing on the affected LR from Switzerland. 
The genetic data was analyzed under the assumption of a shared founder mutation 
and an autosomal recessive mode of inheritance (III/Fig. 2B). Parametric linkage 
analysis within the Finnish LR family revealed positive LOD scores for 25 genomic 
loci, comprising altogether 276 Mb of sequence (III/S1 Table). Homozygosity mapping 
in the three affected dogs identified simultaneous allele sharing across 38 Mb of 
sequence, within 11 genome regions (III/S2 Table). Three chromosomal segments on 
canine chromosomes 11, 13 and 20 overlapped in these two analyses, and had a 
combined size of 19 Mb (III/S3 Table). The whole genome sequence of the affected 
LR contained ~2.9 million homozygous variants, altogether 31,016 of which were found 
within the three critical loci on chromosomes 11, 13 and 20 (III/Table 1). However, 
when the variants present on the three critical regions were filtered against variants that 
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were present in the genomes 118 dogs from various different breeds, only five LR 
specific variants remained, one of which was predicted to have a protein-level effect 
(III/Table 2). This particular variant was a missense change, c.1288G>A; p.Ala430Thr, 
in the autophagy-related 4D cysteine peptidase (ATG4D). The other four variants 
comprised three intronic single nucleotide changes and one intergenic small deletion 
(III/Table 2). 
The ATG4D c.1288G>A variant was genotyped in our entire LR sample cohort of 
2,352 dogs. Within this cohort, 2,061 (88%) dogs had a wild-type genotype, 266 (11%) 
dogs were heterozygous, and 25 (1%) dogs were homozygous for the variant (III/S5 
Table). The overall frequency of the variant allele was 7%. Compatible neurological 
signs were present in 22 out of the 25 homozygous animals, seven of which were 
confirmed as affected through post-mortem examination and three through a skin biopsy 
(III/ S6 Table). Clinical signs could not be ascertained in three adult dogs that were 
homozygous for the missense change. Two of these, a 4-year-old and a 7-year-old dog, 
had possible mild neurological signs, but one 12-year-old animal appeared completely 
unaffected when reviewed through video material. The variant was not present in 642 
dogs from 40 other breeds (III/S5 Table). In the LR cohort, the statistical association 
between the ATG4D variant and disease was highly significant (p = 3.8 x 10-136).  
The mammalian ATG4D protein is one of four ATG4 family members (ATG4A-D) 
that function as cysteine proteinases in the macroautophagy pathway (Marino et al. 
2003). The ATG4 proteins are thought to play a role in the biogenesis of 
autophagosomes (Kaufmann et al. 2014). The identified c.1288G>A variant was located 
in the last exon of the ATG4D gene, and the resulting p.Ala430Thr amino acid change 
was positioned in the carboxy-terminus of the protein, immediately downstream of the 
principal functional C54 peptidase domain (III/Fig. 3A, B, C). The 430-alanine position 
was found to be moderately conserved in evolution, which may indicate functional 
significance (III/Fig. 3D, E). However, the p.Ala430Thr change in affected dogs was 
not estimated to have a damaging effect on protein function by bioinformatics tools. 
Analysis of the ATG4D transcript in cerebellar tissue through RT-PCR and sequencing 
did not reveal differences between affected and healthy dogs, either in mRNA splicing 
or in expression levels (III/S2 Fig.).  
??????Affected tissues show signs of altered autophagic flow 
The function of the ATG4D gene in macroautophagy prompted us to examine whether 
the autophagy-lysosome pathway is disturbed in the affected nervous tissue. For this 
purpose, we utilized immunohistochemistry and several different autophagy and 
lysosomal markers. The autophagosome membrane marker LC3B was detected in 
several PCs within the affected cerebellar cortex (III/Fig. 4E) and in the axonal 
spheroids (III/Fig. 4A), suggesting either induction of autophagy or blockage in the 
autophagy pathway. The granular core of the axonal spheroids showed positivity for 
ubiquitin and p62 (III/Fig. 4B, C). Given that ubiquitin marks degradation-bound 
cellular material and p62 in turn binds ubiquitinated materials destined for autophagy, 
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these findings may also indicate disturbed autophagy. Some neuronal vacuoles were 
positive for the lysosome marker LAMP2 (III/Fig. 4F), suggesting these could be 
secondary lysosomes or autolysosomes. However, some of the vacuoles did not stain 
with any of the used antibodies, leaving their characterization open. Overall, these 
results suggested alterations in the autophagic flux within affected neurons, but further 
examinations are required to obtain a more detailed picture concerning the nature of the 
pathological changes. 
5.4.4 Zebrafish knockdown of atg4da reveals CNS abnormalities 
Given that the functional importance of ATG4D is not well established, we utilized the 
zebrafish model to explore its role during development. For this purpose, we used the 
splice morpholino technique to knockdown the zebrafish homologue atg4da. The 
efficiency and transcript level consequence of the atg4da splice morpholino 
(atg4daSMO) was evaluated by RT-PCR, revealing skipping of exon three in the 
morphant embryos (III/Fig. 5G). Inspection of the morphant phenotype at 1 day post-
fertilization (dpf) indicated severe CNS malformations and widespread 
neurodegeneration in comparison to the control embryos (III/Fig. 5A-D). The affected 
CNS regions corresponded to the cerebellum, hindbrain and midbrain-hindbrain 
boundary. At 2 dpf, the morphant embryos exhibited small-sized brain and eye, mild 
hydrocephalus and occasional pericardial edema (III/Fig. 5E and F). Within the 
cerebellar cortex, immunostaining with PC and granule cell markers revealed marked 
loss of both cell types at 4.5 dpf (III/Fig. 6). Overall, the severe phenotype caused by 
the knockdown of the zebrafish atg4da gene implicates an important role for the gene 
during CNS development.  
5.4.5 ATG4D mutation strengthens the link between autophagy and 
neurodegeneration 
The results of this study suggest that a previously unknown neurodegenerative disease 
in the LR breed is caused by a missense change in the autophagy-related ATG4D gene. 
The disorder is characterized clinically by cerebellar ataxia with a juvenile or adult 
onset, and pathologically by cytoplasmic cellular vacuolization. In support of the 
genetic association, immunohistochemical findings in affected canine brain tissues 
suggested altered autophagic flux, and a knockdown of the zebrafish homologue 
resulted in marked neurodevelopmental alterations and neurodegeneration. 
Our genetic data revealed a highly significant association between the canine disease 
and the ATG4D c.1288G>A variant, representing the first link between the ATG4D gene 
and an inherited disease. Sequencing of the ATG4D transcript did not indicate 
differences in transcript splicing or expression levels between affected and healthy 
dogs, suggesting a possible protein-level functional change. However, on the basis of 
the pathogenicity prediction results and the severe phenotype of the morphant zebrafish, 
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it is probable that the resulting p.Ala430Thr amino acid change does not cause a 
complete loss of ATG4D function. Furthermore, clinical information obtained from LRs 
homozygous for the ATG4D variant indicates variable expressivity and possible 
incomplete penetrance. The age of onset and rate of disease progression varied 
considerably in the affected dogs, and clinical signs could not be confirmed in three 
homozygous animals. It is therefore conceivable that other genetic factors and/or 
environmental modifiers influence the phenotype. However, since direct proof of 
pathogenicity is still lacking, it remains a possibility that the actual causative variant is 
in LD with the presently identified ATG4D change. As this thesis was being written, 
two new affected LRs homozygous for the ATG4D variant were identified. Both dogs 
presented with progressive cerebellar signs, and the other underwent post-mortem 
examination, revealing similar vacuolization that was present in other pathologically 
examined dogs. 
The evolutionary conserved macroautophagy pathway maintains cellular 
homeostasis both under normal and stressful conditions by recycling nutrients and 
disposing damaged cellular materials via the double-layered autophagosomes (Boya et 
al. 2013). The pathway is orchestrated by an array of autophagy-related (ATG) proteins 
(Kaufmann et al. 2014), whose roles have been delineated in yeast studies. The yeast 
possesses only a single Atg4 protein, which functions as a processor of the 
autophagosome membrane protein Atg8 (Fig. 6) (Lang et al. 1998, Kirisako et al. 2000, 
Ichimura et al. 2000). Unlike yeast, higher organisms possess several homologs of the 
yeast Atg4 and Atg8 proteins (Fig. 6) (Xin et al. 2001, Marino et al. 2003, He et al. 
2003, Shpilka et al. 2011). Their particular roles and degree of redundancy are not yet 
well-established, although there are indications of differential functions (Xin et al. 
2001, Weidberg et al. 2010, Li et al. 2011).  
Dysfunction of the autophagy pathway has been associated with several 
neurodegenerative diseases, but reports of disease-causing mutation in the core 
autophagy components are rare. A recent study links an ATG protein with a 
neurodegenerative disorder in humans. Disease-causing mutations were identified in the 
human WDR45 gene, which is a mammalian homolog of the yeast Atg18 gene (Saitsu et 
al. 2013). The resulting disease phenotype is a severe autosomal recessive disorder, 
known as static encephalopathy of childhood with neurodegeneration in adulthood 
(Saitsu et al. 2013). In mice, neuronal deficiency of the autophagy proteins Atg5 and 
Atg7 causes neurodegeneration (Hara et al. 2006, Komatsu et al. 2006), and the loss of 
Atg5 results specifically in PC degeneration (Hara et al. 2006).  
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Figure 6. The ATG4 proteins function in the macroautophagy pathway. Mammals possess 
four homologs of yeast Atg4 and at least seven homologs of the yeast Atg8. Atg8 
and its mammalian homologs are needed for autophagosome formation and are 
also thought to facilitate cargo recognition through interaction with autophagic 
adaptors, such as the p62, which binds ubiquitinated targets. The macroautophagy 
pathway is negatively regulated by mTOR (via the TORC1 complex), whose 
suppression activates downstream regulators, such as the ULK1 and PI3 kinase 
complexes. Two ubiquitin-like conjugation systems are needed for the elongation of 
the forming autophagosomal membranes: the Atg12-Atg5 system and the Atg8 
system. The Atg12-Atg5-Atg16 complex forms via the E1-like and E2-like activities 
of the Atg7 and Atg10 proteins, respectively. The Atg4 protease functions in the 
Atg8 conjugation system. Atg8 is cleaved by Atg4, enabling a covalent attachment 
of the lipid phosphatidylethanolamine (PE) to Atg8. This process is carried out by 
the enzymatic activities of Atg7 (E1-like), Atg3 (E2-like) and the Atg12-Atg5-Atg16 
complex (E3-like). As the autophagosome fuses with the lysosome to form the 
autolysosome, the Atg8 proteins at the inner membrane are degraded, whereas 
those at the outer membrane can be recycled, via delipidation of Atg8-PE by Atg4. 
Figure is adapted from Weidberg et al. 2011, Fleming et al. 2011 and Nixon 2013. 
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The most striking histological change in affected dogs was cytoplasmic vacuolization, 
present in both neuronal and extraneuronal tissues. Within the CNS, the cerebellum was 
one of the most severely affected organs and showed degenerative changes. In line with 
this, publicly available ATG4D expression data from mice indicates especially high 
expression levels in the adult cerebellum in comparison to other brain regions 
(Magdaleno et al. 2006) (http://www.informatics.jax.org/assay/MGI:4945783). The 
intracellular vacuolization in affected dogs was reminiscent of LSDs. However, we 
were unable to recognize any specific material within the intracellular vacuoles, which 
for the most part, appeared empty. Some of the neuronal vacuoles in affected dogs 
stained positive for the lysosomal marker LAMP2, suggesting an alteration in lysosomal 
homeostasis, which is not surprising as the lysosomal and autophagosomal systems are 
closely connected (Korolchuk et al. 2010). Many of the extraneuronal findings in 
affected LRs were found within secretory epithelial tissues, although they did not 
appear to result in specific clinical signs. It remains to be uncovered, whether the 
affected neurons and other affected tissues simply have a high basal demand for 
autophagy or whether ATG4D plays some other roles in these tissues, for instance, in 
secretion-related vesicular trafficking. Interestingly, recent studies have implicated the 
autophagy proteins to function in different secretion pathways (DeSelm et al. 2011, 
Torisu et al. 2013, Ohman et al. 2014, Ponpuak et al. 2015). Overall, the 
neurodegenerative disease in LRs does not seem to fall into the category of classical 
LSDs, but could rather be placed among a broader spectrum of neurodegenerative 
diseases that are characterized by defective clearance of cellular cargo through the 
network of secretory, endosomal, autophagic, lysosomal and exocytic pathways (Boland 
& Platt 2015). 
As a whole, our findings suggest that the autophagy-related ATG4D gene is 
important for neuronal homeostasis and survival. The results of this study strengthen the 
link between the autophagy-lysosome pathway and neurodegeneration. It is plausible 
that similar phenotypes in other species may also result from ATG4D mutations. The 
canine phenotype serves as a platform to study the physiological role of the ATG4D in 
more detail, and to delineate the pathological mechanisms that lead to the observed 
vacuolar changes and neuronal degeneration. Finally, our results have provided a 
genetic test that can be used for both veterinary diagnostic and breeding purposes.  
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6 Concluding remarks 
By utilizing the canine model and its unique genetic features, this thesis has provided 
insights into the molecular genetics of three inherited diseases in dogs. The results of 
this study have had both basic biological and practical significance by revealing new 
disease-associated genes and pathways, by implicating three novel candidate genes for 
corresponding human diseases, and by providing diagnostic help and breeding tools for 
veterinarians and dog owners.  
Dwarf dogs from two different breeds were found to have a nonsense mutation in 
the ITGA10 gene. The mutation is likely to result in a complete loss-of-function of the 
heterodimeric collagen-binding α10β1 integrin. The loss of the α10-integrin subunit was 
previously reported to cause mild chondrodysplasia in mice, whereas the affected dogs 
presented with more pronounced skeletal changes. Our results suggest that the α10β1 
integrin has a critical role in skeletal development especially in larger-sized mammals. 
The SEL1L gene was implicated in an early-onset ataxia and the ATG4D gene in a 
later onset neurodegenerative disease. Interestingly, both genes function in degradative 
pathways, SEL1L in ER-associated protein degradation, and ATG4D in the autophagy 
pathway. The involvement of degradative pathways in neurodegeneration has emerged 
as a common theme, and our findings may help understand their role in disease 
pathogenesis. Further studies are necessary to delineate exact the mechanisms through 
which the disease-associated SEL1L and ATG4D variants cause neuronal degeneration. 
More detailed characterization of the pathological mechanisms could, for instance, have 
implications for the development of therapy options. In addition, the canine models may 
prove helpful in studying the functional importance of the defective genes outside of the 
nervous system. Collaboration with researchers from the Columbia University has 
already explored the role of SEL1L in liver function in affected FH dogs (Wu et al. 
submitted).  
The genetic studies in this thesis were performed in close collaboration with 
veterinary clinicians and pathologists. Especially in the neurodegenerative diseases, 
neurological and pathological examinations were necessary to ascertain the affection 
status of the studied animals. Overall, this collaboration between clinicians and basic 
researchers was instrumental in the successful identification of the disease-associated 
genetic variants. 
This thesis showcases the benefits of the dog in identifying disease-associated loci 
and gene variants by using genome-wide approaches and small sample numbers. The 
genome sequence of the domestic dog was released shortly before this thesis work was 
initiated, and during the study, the available genomic tools became more sophisticated. 
The genetic examinations in this thesis started with a candidate gene approach, and from 
there, the utilized methods evolved from 22K canine SNP chips to 170K SNP arrays, 
and finally, to whole-genome sequencing. In studies I and II, genome-wide significant 
disease loci were first mapped by using SNP arrays, and the causative variants were 
then identified through Sanger sequencing. In study III, several suggestive disease loci 
were identified by performing linkage analysis and homozygosity mapping in a limited 
number of samples. Combining these results with genome-wide sequence data from one 
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affected dog led to the identification of the disease-associated variant. At the moment, 
next-generation sequencing technologies are rapidly becoming a predominant method in 
identifying causative variants in dogs, as well as in other species. However, association 
and linkage information can still significantly aid in identifying causative mutations, 
particularly in dogs, which currently lack the comprehensive variation databases that are 
available for human genetic studies. 
A direct practical application of this thesis has been the development of genetic tests 
for the affected breeds. The tests can be of use in veterinary diagnostics, as well as in 
breeding programs. A large number of dogs were already tested as a part of this study. 
The owners of over 4,300 dogs received a test result based on the finding of this thesis 
work. The current commercial tests have been well accepted by breed clubs, and are 
used as part of the breeding programs. As a general guideline, breeders have been 
instructed not to discard all disease carriers from the breeding population. For instance, 
our results indicate that over 20% of Norwegian Elkhounds carry the ITGA10 mutation, 
and exclusion of all carriers from the breeding population could therefore impact the 
breed’s genetic diversity. However, with the help of the genetic testing, the disease-
causing alleles are likely to eventually disappear from the breeds. In the meantime, the 
birth of affected puppies can be prevented by only mating carrier dogs with non-
carriers.  
This thesis work was critically dependent on the willingness of the dog owners to 
participate in the research, and to provide blood samples and health information from 
their pet dogs. Blood samples were received from various different countries, from as 
far away as New Zealand, which is an indication of the importance the canine genetic 
research holds for individual owners and breeders. During the course of this thesis 
work, the number of samples within the research group’s DNA bank increased by tens 
of thousands. Many of the samples used in this work were initially collected for other 
projects, and samples obtained for this study will hopefully be of help in other research 
projects in the future. 
To conclude, the genetic research performed on dogs has great potential to uncover 
the genetic basis of various different disease phenotypes, which can be of use to canine 
health, human health and basic research alike. This is achievable through the 
collaboration and shared efforts of dog owners, breed clubs, veterinary specialists and 
researchers. 
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